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Abstract
In human cytomegalovirus (HCMV), tropism to epithelial and endothelial cells is dependent
upon a pentameric complex (PC). Given the structure of the placenta, the PC is potentially
an important neutralizing antibody target antigen against congenital infection. The guinea
pig is the only small animal model for congenital CMV. Guinea pig cytomegalovirus
(GPCMV) potentially encodes a UL128-131 HCMV PC homolog locus (GP128-GP133). In
transient expression studies, GPCMV gH and gL glycoproteins interacted with UL128,
UL130 and UL131 homolog proteins (designated GP129 and GP131 and GP133 respec-
tively) to form PC or subcomplexes which were determined by immunoprecipitation reac-
tions directed to gH or gL. A natural GP129 C-terminal deletion mutant (aa 107–179) and a
chimeric HCMV UL128 C-terminal domain swap GP129 mutant failed to form PC with other
components. GPCMV infection of a newly established guinea pig epithelial cell line required
a complete PC and a GP129 mutant virus lacked epithelial tropism and was attenuated in
the guinea pig for pathogenicity and had a low congenital transmission rate. Individual
knockout ofGP131 or 133 genes resulted in loss of viral epithelial tropism. AGP128mutant
virus retained epithelial tropism and GP128 was determined not to be a PC component. A
series of GPCMVmutants demonstrated that gO was not strictly essential for epithelial
infection whereas gB and the PC were essential. Ectopic expression of aGP129 cDNA in a
GP129mutant virus restored epithelial tropism, pathogenicity and congenital infection.
Overall, GPCMV forms a PC similar to HCMV which enables evaluation of PC based vac-
cine strategies in the guinea pig model.
Author Summary
Congenital CMV is a leading cause of mental retardation and deafness in newborns. An
effective vaccine against congenital CMV remains an elusive goal. HCMV encodes a
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pentameric glycoprotein complex (PC) necessary for tropism to epithelial, endothelial and
myeloid cells. Given the structure of the placenta, the viral PC is considered important for
congenital infection and potentially an important neutralizing antibody vaccine target
antigen. The guinea pig, with a placenta structure similar to humans, is the only small ani-
mal model for congenital CMV. In this paper, GPCMV is shown to encode a homolog PC
which enables epithelial tropism on a newly established cell line. It is likely that the
GPCMV PC improves virus tropism to various cell types as PC positive virus has
improved virus pathogenicity and congenital infection in vivo. This study lays important
foundations for development of a PC based intervention strategy against congenital CMV
in this model.
Introduction
Human cytomegalovirus (HCMV or Human herpesvirus 5) is a member of the Betaherpesviri-
nae genus and encodes over 165 genes [1]. Viral infection is largely asymptomatic in healthy
individual but establishes a lifelong mainly latent state in the host. However, infection of an
immune compromised host (AIDS and transplant patients) or virus reactivation because of an
impaired immune system can have severe consequences of morbidity or mortality [2, 3]. An
additional important aspect of HCMV is congenital infection, where the virus crosses the pla-
centa and infects the fetus in utero. This occurs in approximately less than 1% of live births [4]
in the US and causes serious symptomatic disease including mental retardation and sensori-
neural hearing loss (SNHL) in newborns [4–8]. The greatest risk of congenital infection is to
mothers who acquire a primary infection during pregnancy and prior immunity can reduce
the risk by up to 69% [9]. Hence, the impact of a vaccine is potentially substantial, especially in
countries where there is a greater risk of primary infection during pregnancy. These regions
include the US, EU and Japan, where up to 50% of women of child bearing age are negative for
HCMV [8, 10]. Licensed HCMV antivirals are available for transplant and AIDS patients but
not congenital CMV [11]. Consequently, development of a vaccine against congenital CMV is
a high priority.
Any proposed intervention for the prevention or treatment of HCMV infection should ide-
ally be evaluated in a pre-clinical model. Unfortunately, HCMV is extremely species-specific.
Consequently, animal model pathogenicity, vaccine and antiviral studies are carried out using
animal-specific CMVs, including mouse, rat, guinea pig and rhesus macaques [12–16]. The
guinea pig is unique insofar as it is the only small animal model to allow the study of congenital
CMV infection, where the virus crosses the placenta and infects the fetus in utero unlike the
mouse model [17]. Both human and guinea pig placentas are hemomonochorial containing a
homogenous layer of trophoblast cells separating maternal and fetal circulation [18–20]. Addi-
tionally, as with human pregnancy, the gestation period (approximately 65 days) can be
divided into trimesters. Importantly, GPCMV congenital infection causes disease in the fetus
and in newborn pups similar to those found in humans including SNHL [21–23]. Conse-
quently, the guinea pig model is best suited for testing of intervention strategies aimed at pre-
venting congenital CMV infection [11, 24, 25].
A major drawback in GPCMV research has largely been overcome by the recent sequencing
of the viral genome and the development of infectious BAC clones of GPCMV [15, 26–29].
Indeed, manipulation of GPCMV BACs has allowed the preliminary study of some viral genes
[11, 30–36]. Additionally, the guinea pig animal genome has been sequenced (http://www.
ensembl.org/Cavia_porcellus/Info/Index) which enables the development of new reagents for
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this model. Analysis of the GPCMV genome [15, 29] indicated that the virus encoded homo-
logs to the HCMV glycoproteins (gB, gH, gL, gM, gN, gO) in genes co-linear with the HCMV
genome (designated GP55, GP75, GP115, GP100, GP73 and GP74 respectively). In HCMV,
these six glycoproteins (gB, gH, gL, gM, gN, gO) are required for fibroblast cell entry and they
form the glycoprotein complexes, gCI (gB), gCII (gM/gN), gcIII (gH/gL/gO) on the viral mem-
brane [37–39]. Additionally, in HCMV these complexes are important neutralizing antibody
targets and as such potential vaccine candidates [40–44]. We recently demonstrated that
GPCMV forms functionally similar glycoprotein complexes and these complexes are essential
for infection of fibroblast cells as well as important target antigens [36]. In both HCMV and
GPCMV, the viral glycoprotein gB is the immunodominant neutralizing viral antigen [45–49].
A recombinant HCMV gB has been investigated as a candidate subunit vaccine in phase II clin-
ical trials but this provides at best approximately 50% efficacy despite high antibody titers [41].
The process of HCMV entry into the cell was assumed to occur via the mechanism of cell
fusion mediated by gB but also requiring other glycoproteins [50–52]. Current studies indicate
that it is the triplex (gH/gL/gO) and specifically gH/gL that promotes gB cell fusion in fibro-
blasts. This is in keeping with the general model for herpesviruses with core fusion being
related to gB and gH/gL [53–58]. However, gM/gN is considered essential for virus infection of
all cell types and is the most abundant complex in the virion [59]. Most of the earlier HCMV
cell entry studies were performed on fibroblast cells with lab adapted strains of HCMV (eg.
AD169). These viral strains lack the capacity to efficiently infect other cell types such as endo-
thelial, epithelial cells. Clinical strains of HCMV also encode a pentameric glycoprotein com-
plex (gH/gL/UL128/130/131) that enables viral entry into epithelial, endothelial and myeloid
cells via an alternative pathway of cell entry that requires the pentameric complex (PC) in asso-
ciation with gB [55, 57, 60–66]. Alphaherpesviruses, unlike CMV, only encode one type of gH/
gL complex. However, some gammaherpesviruses (eg. Epstein-Barr virus) encode two different
gH/gL complexes to enable gB fusion into different cell types entry which potentially provides
a model for CMV [54]. It is likely that gH/gL based complexes work upstream of gB for cell
entry but this is poorly defined [58]. The alternative route of CMV cell entry will be referred to
as the PC dependent pathway in this report. However, studies suggest that gO, which is unique
to all CMV, also enhances infection of epi/endothelial cells by an undefined mechanism [67].
PC dependent virus infection of epithelial and endothelial occurs via a clathrin-independent
endocytosis pathway with the endosomes undergoing an acid flux [61, 68]. PC dependent virus
infection of dendritic cells is independent of pH but dependent upon cholesterol via macropi-
nocytosis pathway [69]. Interestingly, a recent study demonstrated that virus entry into fibro-
blast cells can also occur via a pH/clathrin independent macropinocytosis pathway in virus
devoid of the PC [70]. Undoubtedly, the PC is necessary for efficient entry into epithelial and
endothelial cells. The viral locus encoding the PC unique genes (UL128-131) is unstable upon
passage of clinical HCMV strains on fibroblast cells and encoded genes rapidly acquire point
mutations or deletions with the subsequent loss of epi/endothelial viral tropism associated with
the inability to form a functional PC [71]. Lab adapted strains of HCMV (eg. AD169) can infect
epi/endothelial cells when the mutated locus is repaired or functional genes are expressed in an
ectopic location which enable PC formation [64, 72, 73]. The basis for HCMV forming gH/gL/
gO triplex or gH/gL PC is poorly defined but both complexes are present on the virion of clini-
cal strains but ratios differ between strains [74]. Potentially, competitive binding of gO or
UL128 with gH/gL might be a key stage but UL148 protein has also been suggested to play a
role in the balance between these complexes [55, 75].
The PC is considered an important neutralizing target for HCMV on epithelial/endothelial
cells and presumably for congenital infection, given the epi/endothelial structure of the pla-
centa [76–78]. The importance of the PC as a target antigen was confirmed by the isolation of
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neutralizing human monoclonal antibodies to the PC which had higher potency than antibod-
ies to other target antigens [76, 77]. In the context of congenital infection, high titer neutraliz-
ing antibodies are thought to be effective against transplacental viral transmission [76, 79, 80].
Potentially, a delay in the immune response to the PC results in fetal infection [81]. The impor-
tance of the PC in virus infection of cells is underscored by a recent finding for the gB subunit
HCMV vaccine. In clinical trials, the gB vaccine induces a high titer neutralizing immune
response which is effective in neutralizing virus on fibroblasts [41, 82]. However, in separate
studies sera from gB vaccinated individuals is less effective at neutralizing virus infection on
endothelial and epithelial cells in comparison to convalescent sera from HCMV infected indi-
viduals [78, 83, 84]. This demonstrated the importance of other viral neutralizing target anti-
gens for infection on these cell types. Consequently, other target antigens should be considered
important in the development of a vaccine against congenital CMV. Importantly, a gB vaccine
fails to fully protect against congenital CMV in the guinea pig model [49, 85, 86].
Potentially, GPCMV encodes a homolog PC as a UL128-131 homolog locus (GP128-133)
was identified in low pass ATCC viral stock of GPCMV, strain 22122 (ATCC VR682) [28, 87].
The sequence of this virus also matched that of salivary gland (SG) GPCMV (extensively seri-
ally passaged in vivo in guinea pigs) [25]. However, a plaque purified isolate (designated PP
ATCC), used to establish the first GPCMV sequence, carried a deletion in this locus [15]. PP
ATCC had normal growth kinetics in tissue culture but was attenuated in vivo compared to SG
GPCMV [25, 26]. We hypothesized that the viral attenuation was linked to the inability of the
virus to form a homolog pentameric complex which impacted on virus cell tropism to specific
cell types (eg. epithelial cells) and consequently pathogenicity in the animal. Virus cell tropism
was evaluated with a newly established guinea pig renal epithelial cell line. The potential inter-
actions of GPCMV homolog glycoproteins gH and gL with proteins encoded in the GP128-133
locus were studied to provide evidence of a GPCMV PC. [63]. Additionally, a GPCMVmutant
virus which encoded an intact locus but a mutated GP129 gene (UL128 homolog) was restored
for epithelial tropism by expression of a full length GP129 cDNA in an ectopic location. This
recombinant virus (GP129FRT) incorporated a myc tagged GP129 into the viral particle as
part of the PC. Knockout of GP129, GP131 or GP133 (UL128, UL130 and UL131 homologs
respectively) in recombinant GPCMV impaired virus replication on epithelial cells but not
fibroblasts. Importantly, virus restored for PC had improved pathogenicity and congenital
transmission rates compared to mutant virus lacking the complex. Overall, the similarity of
function between HCMV and GPCMV pentameric complexes strengthens the guinea pig
model in the development of an effective preclinical vaccine strategy against epithelial and con-
genital infection based on the CMV PC.
Results
GPCMV epithelial tropism requires a full length UL128-131 homolog
locus
In earlier reported studies of GPCMV, strain 22122 (ATCC VR682), the pathogenic salivary
gland (SG) virus was maintained by serial passage in animals but could be attenuated by exten-
sive serial passage of the virus on fibroblast cells,>11–25 passes [21, 88, 89]. However, the
molecular basis for this attenuation was undefined and the viral stocks of the SG and fibroblast
passaged virus are no longer available (Griffith (Yale University, CT) personal communication
to AM). A potential basis for the viral attenuation in GPCMVmight be by modification of a
homolog UL128-133 locus [28, 87, 90]. In clinical HCMV strains, adaptation of the virus to
growth on fibroblast cells rapidly resulted in mutations in this locus and impaired virus tro-
pism to various cell types [60, 71, 91]. Inoue and colleagues [87] identified two variants of
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GPCMV in low pass ATCC stock of GPCMV (strain 22122). One GPCMV variant was intact
for the homolog UL128-131 locus (GP128-GP133), whereas the other carried a deletion in the
locus and was similar in sequence to the tissue culture adapted GPCMV isolate [15, 29].
GPCMV, strain 22122 (ATCC), was serially propagated in guinea pigs at Children’s Hospital
Research Foundation, Cincinnati (Ohio, USA) from the late 1980s-2005. Salivary gland (SG)
viral stocks were extensively used in congenital GPCMV challenge studies by a number of
investigators. This SG virus stock was recently sequenced and shown to encode a full length
GP128-133 locus [92], whereas the tissue culture adapted virus derived from the SG GPCMV
stock used to establish the first viral genome sequence carried a deletion in this locus [15]. In
this present study, GPCMV salivary gland stock SG11 (11 direct serial passages in guinea pigs)
was used to evaluate the sequence of the GP128-133 locus in the virulent virus. Additionally,
plaque purified (PP ATCC) virus stock extensively passaged on fibroblast cells was used to
evaluate the sequence of lab adapted virus. PCR primers ([87], S1 Table) were used to amplify
the GP128-GP133 locus and the PCR product cloned prior to sequencing. Fig 1(i) shows the
structure of the GP128-133 locus and the analysis of the cloned PCR products for the GP128-
133 locus from respective viruses. Sequence analysis of the cloned PCR products (see Fig 1(ii)A
and S1 Fig) confirmed that the two virus stocks (SG GPCMV and PP ATCC plaque isolate) dif-
fered in an identical fashion to the two isolates reported in low pass ATCC stock [28, 87]. The
SG GPCMV had a complete GP128-133 locus (2 kb PCR product), whereas the PP ATCC virus
[26] carried a 1.6 kb deletion (0.4 kb PCR product) which removed the majority of the GP129-
133 coding sequence (196,925–198,573) as shown by PCR analysis (see Fig 1(ii)A). This poten-
tially supports the hypothesis that a full length GP128-133 locus is necessary for full tropism/
pathogenicity in vivo since GPCMVmutated in the GP128-133 locus is attenuated in the ani-
mal model [29]. RT-PCR at late stage infection confirmed transcription of genes encoded in
the GP128-133 locus in SG GPCMV infected cells (S2 Fig).
In HCMV, a consequence of adaptation of clinical strain virus to fibroblast cells is an inabil-
ity for the virus to form a functional PC (gH/gL/UL128-131) necessary for infection of epithe-
lial or endothelial cells and other cell types [60, 62–64, 71]. Potentially, GPCMV encodes a
homolog PC but cellular tropism associated with this locus has not been successfully demon-
strated [90] except for infection of macrophage [93]. A major limitation in GPCMV studies is
the availability of different types of tissue culture cell lines to evaluate virus tropism. Conse-
quently, we generated a novel guinea pig renal epithelial cell line from the kidney. Colonies
were clonally isolated, characterized by cytokeratin marker and cell lines immortalized as
described in materials and methods. Epithelial cells were characterized by assay for cytokeratin,
either by western blot or immunofluorescence assay (see S3 Fig). The guinea pig epithelial cells
were positive for cytokeratin unlike GPL cells (S3 Fig). Importantly, SG GPCMV was capable
of infecting and replicating on epithelial cells. Fig 1(ii) shows virus infected epithelial cells co-
stained for cytokeratin (cytoplasm) and GPCMV IE2 protein (nucleus), see panels C and B
respectively. In contrast, viral antigens failed to be detected in PP ATCC GPCMV infected epi-
thelial cells (S4 Fig) but control studies demonstrated virus infection of fibroblast cells (S4 Fig).
Additionally, a growth curve of SG GPCMV vs PP ATCC demonstrated that virus with an
intact GP128-133 locus can infect and replicate on epithelial cells, whereas the PP ATCC
mutant virus was highly impaired for growth on epithelial cells, see Fig 1(iii)A. In contrast,
both viruses were capable of normal growth on fibroblast cells (Fig 1(iii)B).
It was concluded that the SG GPCMV has the ability to replicate on epithelial cells, unlike
lab adapted GPCMV. Additionally, tropism was a result of a SG GPCMV virus encoding a
complete GP128-133 locus unlike lab adapted virus. This could be verified by comparative
sequence analysis between isolates which indicated that the only difference between viruses
related to the GP128-133 locus [29, 87, 94].
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Pentameric glycoprotein complex formation and impact of GP129
mutants
In order to study GPCMV pentameric glycoprotein complex formation, full length cDNA
clones of GP128, GP129, GP131 and GP133 were cloned into mammalian expression vectors or
Fig 1. Structure of GPCMVUL128-131 (GP128-GP133) homolog locus and wt or mutant virus growth on epithelial or fibroblast
cells. (i) Layout of the GPCMVGP128-133 locus of genes. Annotated GPCMV genome (co-ordinates 195,713–199,263 nucleotides)
which encodesGP128-gp134. Individual genes represented as blue arrows and direction indicates either sense (above line) or
complementary strand (below line) coding. Direct homologs to HCMV pentamer complex genes are UL128 (GP129), UL130 (GP131),
UL131 (GP133).GP129 (3 exons) andGP131 (two exons) are spliced genes. P1 (196,707) and P2 (198,701) show the location of the PCR
primer pair (P1/P2) used to amplify theGP128-GP133 locus genes. The top line shows amplification of the full length locus (2 kb) from SG
GPCMV. The bottom line shows amplification of the deletedGP128-GP133 locus in PP ATCC lab adapted virus (0.4 kb). Solid line
indicates conserved sequence between full length locus and dotted line indicates deleted sequence. Co-ordinates 196,925–198,573
nucleotides represent the specific deletion within the locus for PP ATCC virus. Specific annotated nucleotide sequence of the
GP128-GP133 locus is shown in S1 Fig. (ii) A. Analysis of full length and truncated viruses and epithelial cell infection. Agarose gel
electrophoresis of the P1/P2 PCR for theGP128-133 locus from GPCMV. Left, kb ladder (Invitrogen). Middle, (ATTC) PP ATCCGPCMV
(0.4 kb). Right, (SG) SG GPCMV (2 kb).B, C and D. Immunofluorescence assay of SG GPCMV infected epithelial cells.B.GPCMV IE2
detected with primary rabbit anti-IE2/ secondary anti rabbit IgG-FITC.C.GPCMV infected guinea pig epithelial cell monolayer verified by
cytokeratin marker staining with primary mouse anti-pancytokeratin/ secondary anti-mouse IgG-TRITC. D.Overlay of B and C with cell
nuclei stained with DAPI. (iii) Comparative growth curve of SG GPCMV and PP ATCC GPCMV on epithelial cells and fibroblast cells. Cells
were infected with either at a moi of 1 pfu/cell. Sample were taken at different days post infection and titrated in duplicate on GPL cells as
previously described [33]. Results plotted as virus titer against days post infection: A, growth on epithelial cells; B, growth on GPL cells.
Diamond (blue), SG GPCMV. Square (red), PP ATCC.
doi:10.1371/journal.ppat.1005755.g001
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recombinant adenovirus vectors under HCMVMIE promoter control as described in materials
and methods [36]. Additionally, ORFs were C-terminal epitope tagged to enable detection:
GP129 (myc); GP131 (HA); GP128 (FLAG); and GP133 (FLAG). Also, previously described
GP75 (gH ORF) and GP115 (gL ORF), C-terminal tagged with GFP or mCherry respectively,
in mammalian expression plasmids or recombinant defective adenovirus [36] were utilized in
the study. All constructs were verified by sequencing and are summarized in S5 Fig.
An initial series of experiments examined the cellular localization of the various GPCMV
proteins. Cells transduced with defective adenoviruses expressing gH, gL, GP129, GP131 and
GP133 resulted in a cytoplasmic co-localization of gH and gL with GP129, GP131 and GP133
(S5 Fig). Next, an immunoprecipitation assay was performed on cells that expressed all the
components of the potential pentameric complex to demonstrate protein:protein interactions.
Fig 2(i) demonstrated that transduction of epithelial cells with recombinant adenovirus encod-
ing a single glycoprotein enabled their successful detection by western blot analysis using their
respective epitope tag marker. Transient expression of gHGFP and gLmCherry have previously
been described [36]. Western blot analysis of transiently expressed GP129myc, GP131HA and
GP133FLAG produced proteins with larger than expected size: GP129myc (expected 24 com-
pared to 40kDa); GP131HA (25 compared to 31 kDa); GP133FLAG (16.7 compared to 19
kDa) (S2 Table). It was presumed that this was a result of post-translation modification such as
glycosylation as previously demonstrated for gH and gL [36]. Potentially, both glycosylated
and non-glycosylated versions of GP131HA are seen in Fig 2(i) as proteins at two different
molecular weights (approximately 31 and 25 kDa) are detected. Treatment of cells with the gly-
cosylation inhibitor tunicamycin (S6 Fig) demonstrated that GP129 and GP131 were subject to
glycosylation as predicted in S2 Table. In the presence of tunicamycin, only lower molecular
weight proteins were detected. Tunicamycin treatment also resulted in proteins appearing
more aggregated in cellular immunofluorescence studies (S6 Fig).
Next, GFP-trap (Chromotek) immunoprecipitation (IP) assays were used to detect interac-
tion with gH-GFP/ PC formation in cells transduced by all five recombinant adenoviruses
(AdgHGFP, AdgLmCherry, AdGP129myc, AdGP131HA and AdGP133FLAG), Fig 2(ii). The
GFP trap approach had previously been used to successfully study GPCMV glycoprotein com-
plexes gM/gN (via gMGFP IP) and gH/gL/gO (via gHGFP IP) [36]. The GFP-trap IP of lysed
cells transduced for all potential PC protein components resulted in the successful IP of
gLmCherry, GP129myc, GP131HA and GP133FLAG by gHGFP (Fig 2(ii)). Interestingly, both
species of GP131HA were immunoprecipitated. In contrast, a control GFP trap IP of cells
transduced with AdGFP, AdgLmCherry, AdGP129myc, AdGP130HA and AdGP133FLAG but
not AdgHGFP resulted in successful IP of GFP but none of the components of the PC (Fig 2
(iii)), which demonstrated the specificity of the IP assay as well as the importance of gH in the
interactions with other PC proteins. A similar series of PC immunoprecipitation reactions
were also performed using RFP-trap (Chromotek) with gLmCherry and control mCherry. All
PC components were able to be precipitated by gLmCherry IP which demonstrated the impor-
tance of gL for PC formation (S7 Fig). A control mCherry in place of gLmCherry failed to
immunoprecipitate components of the PC (S7 Fig)
Next, we investigated the impact of C-terminal GP129 (UL128 homolog) mutants on the
ability to form a pentameric complex with other GPCMV proteins. An initial study was carried
out with a natural GP129 mutant. The second generation GPCMV BAC derived virus encodes
the full spectrum of viral genes [29, 95] but contains a 4 bp deletion in the GP129 gene, which
places the ORF out of frame and truncated the encoded protein at codon 102 (NRD13, see S8
Fig). Virus derived from this BAC has normal growth kinetics on fibroblast cells but lacked the
ability to grow on epithelial cells (see section on restoration of epithelial tropism). A cDNA
clone of the truncated GP129 mutant (designated GP129NRD13) was myc-epitope tagged and
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cloned into a transient expression vector and assayed for an ability to form a PC in a GFP trap
immunoprecipitation assay. Despite detectable GP129NRD13 expression levels, the protein
failed to be immunoprecipitated as part of a PC (Fig 3). This indicated the importance of the
C-terminal domain of GP129 in complex formation. A chimeric GP129 C-terminal mutant
was also generated synthetically that encoded the C-terminal domain of HCMV UL128 (Mer-
lin strain) in place of GP129 after the NRD13 truncation site (designated GP129UL128, see S8
Fig). In transient expression studies, the GP129UL128 chimeric protein failed to form a PC
Fig 2. Immunoprecipitation of GPCMV pentameric complex. (i) Individual expression of pentameric
complex components in epithelial cells transduced with recombinant adenovirus encoding either gHGFP,
gLmCherry, GP129myc, GP131HA or GP133FLAG analyzed by western blot using respective primary
antibodies: gH (anti-GFP); gL (anti-mCherry); GP129 (anti-myc); GP131 (anti-HA); GP133 (anti FLAG).
Bands visualized with appropriate secondary antibody-HRP conjugate as described in materials and
methods [36]. Lys indicates defective adenovirus transduced lane and MI indicates mock cell lysate. (ii)
Immunoprecipitation of the pentameric complex from epithelial cells transduced with all five recombinant
defective adenoviruses encoding individual components (10 TDU/virus/cell). Samples were analyzed as total
cell lysate as above or processed for immunoprecipitation assay. Immunoprecipitation was carried out with
GFP trap as previously described [36]. Individual proteins were detected as described for (i). Western blot
lanes: 1–3 (anti-mCherry); 4–5 (anti-GFP); 6–8 (antiFLAG); 9–10 (anti-myc); 11–12 (anti-HA). Lanes 1
and 6 mock infected cell lysate. Lanes 2, 4, 7, 9 and 11 (total cell lysate). Lanes 3, 5, 8, 10 and 12
(immunoprecipitation). (iii) Control PC immunoprecipitation assay with GFP substituting for gHGFP.
Epithelial cells transduced with defective recombinant adenoviruses encoding GFP, gLmCherry GP129myc,
GP131HA and GP133FLAG followed by GFP immunoprecipitation and western blot for proteins as
previously described [36]. Western blot lanes: 1–4 (anti-GFP); 5–7 (anti-mCherry); 8–11 (anti-myc); 12–14
(anti-HA); 15–17 (anti-FLAG). Lanes 1 and 8 mock infected cell lysate. Lanes 2, 5, 9, 12 and 15 (total cell
lysate). Lanes 3, 6, 10, 13 and 16 (flow through). Lanes 4, 7, 11, 14 and 17 (immunoprecipitation).
doi:10.1371/journal.ppat.1005755.g002
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with other components (Fig 3). This indicated that there was insufficient conservation between
the C-terminal domains of GPCMV GP129 and HCMV UL128 to enable PC formation.
Although the GP129 mutants could not be precipitated as part of a PC, the gHGFP immuno-
precipitation reactions did pull down other components of the complex (gL, GP131 and
GP133). Potentially, components of the PC were capable of forming subcomplexes with gH/gL.
Consequently, the ability of GP129, GP131 and GP133 to independently form triplexes with
gH/gL was investigated. In transient expression immunoprecipitation assays based on gHGFP,
gH/gL formed triplex complexes with GP129, GP131 or GP133 (Fig 3). Protein cellular co-
localization could also been demonstrated in the cytoplasm of epithelial cells (Fig 4 and S9
Fig). The relevance of the various subcomplex triplexes to the PC or to the gH/gL/gO triplex
formation and viral assembly remains to be more fully investigated in future studies but would
indicate that gH/gL interaction is not solely dependent upon GP129. Subcomplex formation
was also investigated for the GP129 mutant. Triplex formation could not be demonstrated to
Fig 3. PC formation and GP129mutants. C-terminal GP129 mutants were evaluated for an ability to form
pentamer complexes with gHGFP, gLmCherry, GP131HA and GP133FLAG. GP129 mutants were
expressed on transient expression plasmids transfected onto epithelial cells. Immunoprecipitation was
carried out using a GFP trap as described in materials and methods. GP129 mutants (NRD13 and
GP129UL128) were detected by a myc epitope tag. (i) PC formation assay using gHGFP and other
components of the PC and GP129 mutant (NRD13) and GFP trap IP. Lanes 1, 5, 9, 13 and 17 are total cell
lysates analyzed by respective antibodies. Lanes 3, 7, 11, 15 and 19 are immunoprecipitation tracks using
GFP trap [36]. Lanes 2, 6, 10, 14, 18 are flow through wash tracks prior to immunoprecipitation. Lanes 4, 8,
12, 16 and 20 are mock cell lysate. Samples were assayed for: gH (anti-GFP), lanes 1–4; gL (anti-mCherry),
lanes 5–8; GP131 (anti-HA), lanes 9–12; GP133 (anti-FLAG), lanes 13–16; and GP129 mutant NRD13 (anti-
myc), lanes 17–20. Secondary antibody was anti-mouse IgG-HRP. (ii) PC formation assay using gHGFP and
other components of the PC and GP129 mutant (GP129UL128) and GFP trap IP. Lanes as described for (i)
except lanes 17–20 GP129UL128 mutant blot.
doi:10.1371/journal.ppat.1005755.g003
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occur with gH, gL and GP129 NRD13 with a similar outcome to that obtained for interaction
with all PC components (Fig 3). This implied that the C-terminal portion of GP129 was also
important for subcomplex formation. Overall, it was concluded that GPCMV forms a homolog
pentameric complex and that the UL128 homolog (GP129), especially the C-terminal domain
is important for complex formation.
Restoration of epithelial tropism in lab adapted GPCMV and requirement
for components of theGP128-133 locus
GPCMV serially passaged in animals as salivary gland stock retained an ability to infect epithe-
lial cells unlike lab adapted virus. The second generation GPCMV BAC encoded a full length
GP128-GP133 locus but carried a 4 bp deletion that truncated the GP129 ORF (NRD13
mutant, S8 Fig) compared to wild type virus [29, 95]. Transient expression of GP129NRD13
protein together with other components of the pentameric complex (gH, gL, GP131 and
GP133) failed to generate a detectable PC (Fig 4). Additionally, BAC derived GPCMV lacked
Fig 4. gH/gL triplex formation with GP129, GP131, GP133 or gO.GP129, GP131, GP133 and gO were evaluated for
an ability to form triplex complexes with gH and gL. Transient expression of epithelial cells with gHGFP, gLmCherry,
GP129myc, GP131HA and GP133FLAG was as described in materials and methods. Evaluation of triplex formation was
by cellular colocalization or by GFP trap immunoprecipitation assay. A-E. gHGFP/gLmCherry/GP129myc triplex
formation. Panels A-D, transient expression of individual proteins in epithelial cells and co-localization shown in merged
image (D). Western blot of triplex immunoprecipitation (E). Lanes 1, 4 and 7 (total cell lysate). Lanes 3, 6 and 9 (IP).
Lanes 2, 5 and 8 (flow through wash). F-J. gHGFP/gLmCherry/GP131HA triplex formation. Panels F-H, transient
expression of individual proteins in epithelial cells and co-localization shown in merged image (I). Western blot of triplex
immunoprecipitation (J) as described for E except lanes 7–9 GP131HA western.K-O. gHGFP/gLmCherry/GP133FLAG
triplex formation. Panels K-M, transient expression of individual proteins in epithelial cells and co-localization shown in
merged image (N). Western blot of triplex immunoprecipitation (O) as described for E except lanes 7–9 GP133FLAG
western. P-T. gHGFP/gLmCherry/gOFLAG triplex formation. Panels P-R, transient expression of individual proteins in
epithelial cells and co-localization shown in merged image (S). Western blot of triplex immunoprecipitation (T) as
described for E except lanes 7–9 gOdelFLAG. Cellular co-localization merged figures (D, K, N and S) include DAPI co-
stained cells. GP129myc, GP131HA, GP133FLAG and gOdelFLAG detected by primary anti-epitope antibody and
secondary anti-mouseIgG-Cy5 (immunofluorescence) and anti-mouseIgG-HRP (western blot). Both gHGFP and
gLmCherry were detected by fluorescence (cell localization) and specific epitope antibody (western). Panels E, J, O and
P western blots. Lanes: 1, 4 and 7 total cell lysate; 2, 5 and 8 wash flow through; 3, 6 and 9 immunoprecipitation.
doi:10.1371/journal.ppat.1005755.g004
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epithelial tropism but grew normally on fibroblast cells (see below) [96]. The capability of BAC
derived GPCMV to form a functional pentameric complex and potentially restore epithelial
tropism was evaluated by the introduction of a full length GP129 cDNA expression cassette
into the GPCMV genome in a non-essential intergenic locus. The intergenic site between UL25
andUL26 homologs (GP25 and GP26) was selected on the basis of co-terminal transcripts ending
in this locus with sufficient intergenic sequence to enable insertion of an ectopic cassette without
interfering with GP25 or GP26 expression based on previous studies [25] (see S10 Fig). A cDNA
myc tagged GP129 ORF used in transient expression studies was cloned initially into a shuttle
vector (pGP2526GP129LinkKm) which placed the GP129 cDNA under SV40 promoter and
SV40 polyA control as described in materials and methods (S11 Fig). Mutant GPCMV BAC
clones were selected by kanamycin (Km) marker. Full length GPCMV BACmutants encoding
GP129myc in the GP25/GP26 locus were verified by restriction enzyme profile analysis (S12 Fig)
and by PCR (S11 Fig) and sequencing. DNA from correctly identified mutant GPCMV BACs
were transfected onto GPL cells to generate virus (GP129FRT). Virus expression of myc tagged
GP129 and protein incorporation into the virus particle was demonstrated by western blot analy-
sis of sucrose gradient purified viral particles. Fig 5 demonstrated that GP129myc was expressed
in virus infected cells. Additionally, that GP129 was present in the purified viral particles as was
GP131, another unique component of the PC. Glycoprotein gH could also be detected in virus
particles, presumably as part of the triplex homolog (gH/gL/gO) and also the pentameric com-
plex (gH/gL/GP129/GP131/GP133). Additionally, gB glycoprotein could be detected as a viral
particle component but not GFP, which was expressed in infected cells but not incorporated into
the viral particle. A growth curve confirmed that GP129FRT GPCMVwas highly trophic for
Fig 5. Ectopic expression of GP129 and incorporation into the virion. (i) Structure of parental BAC virus
(NRD13) and modified mutant GP129FRT GPCMV. Modified mutant encodes an ectopic GP129 (myc
tagged) cDNA under SV40 promoter control in theGP25/GP26 intergenic locus as described in materials and
methods (S14 Fig). Arrows (right) indicate virus tropism to epithelial cells: red, no tropism; green, tropism. (ii)
Western blot analysis of sucrose gradient purified GP129FRT. Purified virus was evaluated for the presence
of structural proteins present in the viral membrane by western blot analysis: gB (detected by mouse anti-gB),
lanes 1–3; gH (rabbit anti-gH), lanes 4–6; GP131 (mouse anti-GP131), lanes 7–9; GP129 (mouse anti-myc),
lanes 10–12. Additionally, a control GFP protein (mouse anti-GFP) expressed by the virus was also evaluated
(lanes 13–15). Secondary antibodies were either anti-mouse IgG/HRP or anti-rabbit IgG/HRP. Lanes: 1, 4, 7,
10 and 13 total cell lysate (GP129FRT); 2, 5, 8, 11 and 14 total cell lysate (uninfected); 3, 6, 9, 12, and 15
(purified virus particle). Equivalent protein loading was determined by Bradford assay.
doi:10.1371/journal.ppat.1005755.g005
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epithelial cells with efficient virus growth (Fig 6). In comparison, the parental derived GPCMV
BAC virus NRD13 which encoded a truncated GP129 but viable GP131 and GP133 failed to effi-
ciently replicate on epithelial cells (Fig 6).
Next, the requirement for other components of the homolog PC for virus growth on epithe-
lial cells was evaluated. Targeted mutagenesis was performed on the GP128-GP133 locus to
generate GPCMV BAC mutants with knockout GP128, GP129-GP131 or GP133 in separate
BAC mutagenesis reactions. Final GPCMV BAC mutants encoded an ectopic GP129 cDNA in
the GP25/GP26 intergenic locus in addition to specific mutations in the GP128-GP133 locus as
described in materials and methods. BAC mutants were characterized by restriction profile
analysis, PCR and sequencing of the PCR product (S12 Fig and S11 Fig). Recombinant viruses
were designated GP128FRT/GP129Link (GP128mutant); GP129-GP131FRT/GP129Link
(GP131mutant); GP133FRT/GP129Link (GP133mutant). Although these viral mutants had
similar growth kinetics on GPL cells, they lacked an ability to efficiently infect epithelial cells
(S13 Fig). The exception was the GP128mutant which retained an ability to infect epithelial
cells (Fig 7). In the case of GP131 and GP133 GFP tagged mutant viruses (non-cre BAC
excised) a contrasting infection could be demonstrated between fibroblast and epithelial cells.
In separate experiments, a moi of 1 pfu/cell resulted in a 100% infection of GPL cells but only
approximately 1 in 106 epithelial cells. Additionally, mutant virus infected epithelial cells failed
to result in virus spread to surrounding cells, unlike GP129FRT or SG GPCMV. Examples of
impaired GP131 and GP133mutant virus growth on epithelial cells compared to GPL cells is
shown in S13(ii) Fig.
Overall, it was concluded that epithelial tropism could be restored to lab adapted GPCMV
by ectopic expression of a missing full length GP129 protein. This virus (GP129FRT) expressed
GP129 and GP131 proteins as part of the viral particle. Knockout of individual genes in the
GP128-GP133 locus in the backdrop of virus expressing the ectopic full length GP129 also con-
firmed the essential role of GP131 and GP133 in PC formation and epithelial tropism. Knock-
out of the GP128 gene did not prevent epithelial tropism and transient expression of GP128
demonstrated that it was a nuclear targeting protein (Fig 7). The functional significance of
GP128 in the GPCMV life cycle remains unknown. BLAST analysis of the predicted GP128
protein sequence indicated that it was a potential homolog of MCMV IE2 [15] and therefore is
unlikely to be relevant to PC formation.
Fig 6. Comparative growth kinetics of GP129FRT and NRD13 GPCMV on epithelial cells.Guinea pig
epithelial cells were infected with either GP129FRT (encoding an ectopic GP129) or NRD13 (encoding a
mutant GP129) at a moi of 1 pfu/cell. Sample were taken at different days post infection and titrated in
duplicate and titrated on GPL cells as previously described [33]. Results plotted as virus titer against days
post infection.
doi:10.1371/journal.ppat.1005755.g006
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Alternative pathway of cell entry can be demonstrated in GPCMV by
elimination of glycoprotein triplex formation (gH/gL/gO) and retention of
glycoprotein PC formation
In a previous study, it was demonstrated that GPCMV forms a homolog gH/gL/gO glycoprotein
triplex and that gO (GP74) was only essential in lab adapted virus which lacked a PC [36]. In an
effort to demonstrate that the PC is more important than the triplex complex for infection of epi-
thelial cells, a series of gO (GP74)/ GP129 mutant GPCMV BACs were transfected onto GPL or
epithelial cells to evaluate virus spread. Three GPCMV BACmutants (Fig 8) were used: (1)
GP74Km, which contains a GP74 knockout on a GPCMV BAC that lacked a full length GP129
[36]; (2) NRD13, GPCMV BAC that lacked full length GP129; (3) GP129FRT/GP74Km, GPCMV
BAC that encoded a GP74 knockout and a full length GP129 cDNA in the GP25/GP26 intergenic
locus. Transfection of GP74KmGPCMV BACDNA (1) onto GPL or epithelial cells failed to
enable the development of viral plaques but instead remained as single transfected cells which
could be identified by GFP reporter gene expression (Fig 8A–8C). Transfection of NRD13 (GP129
mutant) GPCMV BAC (2) onto GPL or epithelial cells resulted in the development of viral pla-
ques and spread on fibroblast cells but failed to produce virus on epithelial cells (Fig 8D–8F).
Transfection of GPCMV BAC GP129FRT/GP74Km onto GPL and epithelial cells resulted in the
development of viral plaques on both cell types (Fig 8G–8I). Importantly, virus derived from BAC
GP129FRT/GP74Km demonstrated that gO was not completely essential for epithelial cell infec-
tion.as virus spread across the entire monolayer of epithelial cells. Although GPCMV infection of
epithelial cells could occur in the absence of gO via the PC, the gB glycoprotein was presumed to
be required for epithelial cell infection as demonstrated for fibroblast cells [36]. In an additional
experiment, a PC+ /gO+/gB (GP55) negative mutant GPCMV BAC (GP129FRT/GP55Km) when
transfected onto epithelial cells failed to produce infectious virus. In contrast, a gB rescue virus
had restored epi-tropism which emphasized the essential nature of the gB protein for epithelial
infection despite the requirement for a PC (S14 Fig)[36]
Fig 7. GP128 is not a component of the pentameric complex and aGP128mutant is not impaired for epithelial cell tropism.
(i)GP128 is a nuclear protein. Transient plasmid co-expression of GP128 (FLAG tagged), gHGFP and gLmCherry at 24 hours post
transfection. Panels A-D same cell. Panel A, immunofluorescence of GP128FLAG (mouse anti-FLAG/ anti-mouse IgG-Cy5); GFP
fluorescence of gHGFP (B); mCherry fluorescence of gLmCherry (C); merged images A-C (D). (ii)GP128 knockout virus
(GPCMVdel128) grows on epithelial cells. E. Immunofluorescence of IE2 (rabbit anti-IE2/ anti-rabbit IgG-FITC). F.
Immunofluorescence of cytokeratin (mouse anti-pancytokeratin/anti-mouse IgG-TRITC). G. Merged image of panels A plus B and
DAPI stained cell nuclei.
doi:10.1371/journal.ppat.1005755.g007
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Since infection of epithelial cells occurred for a PC+/gO negative virus but not for a PC neg-
ative/gO+ virus, we concluded that epithelial cell infection is not absolutely dependent upon
gO or the gH/gL/gO triplex but the PC is essential for epithelial cell infection. Admittedly, this
particular assay was relatively crude since it fails to fully discriminate between cell to cell spread
and infection from cell release virus. However, the strategy demonstrated an importance of the
PC for epithelial cell infection. A similar approach defined the essential nature of the GPCMV
glycoproteins (gB, gH, gL, gO, gM and gN) for fibroblast cells [36]. In HCMV, a PC+/gO
+ virus can more easily infect epithelial cells than a PC+/gO negative virus [67]. Therefore in
HCMV, gO has an undefined role in infection of cell types other than fibroblasts via an unde-
fined mechanism [36]. The role of gO in potentially enhancing GPCMV infection of epithelial
cells and other cells types remains to be evaluated.
In HCMV, PC dependent infection of epithelial and endothelial cells occurs via an endocy-
tic pathway that requires an acid flux in the endosome [61]. The antibiotic bafilomycin pre-
vents HCMV infection of epi/endothelial cells by inhibiting the ATPase and subsequent
acidification of the endosome [61, 97, 98]. Pretreatment of guinea pig epithelial cells with
50nM bafilomycin dramatically inhibited virus infection of epithelial cells but did not greatly
impact on fibroblast cell infection (S15 Fig). This potentially indicated that GPCMV entry into
epithelial cells is via a similar pathway to HCMV. More focused future studies on the process
of GPCMV entry into epithelial cells might provide better insight into the entry pathway for
GPCMV and the similarity to HCMV. Analysis of the level of PC compared to gH/gL/gO on
GPCMV particles might be worthy of future investigation as this might help to define virus cell
tropism.
Fig 8. PC+/gO negative GPCMV demonstrates that infection of epithelial cells is independent of the
gH/gL/gO triplex.GPCMV BACmutants were transfected onto cells (GPL and EPI) to generate GFP
positive virus and to demonstrate a requirement for the pentameric complex but not the triplex for epithelial
cell tropism. GPCMVmutants: (A) NBGP74Km, a double mutant, gO (GP74Km) and GP129 mutant
(NRD13); (D) NBNRD13, a GP129 mutant (NRD13); (G) NBGP129FRT/GP74Km, a double mutant, gO
(GP74Km) and GP129 (NRD13) plus ectopic expression of full length GP129myc (GP26/GP26 locus). Virus
determined by GFP reporter gene spread across the cell monolayer. Results shown are at approximately 18
days post BAC transfection for both GPL and EPI cells for each virus. Panels B and C, NBGP74Km. Panels E
and F, NBNRD13. Panels H and I, NBGP129FRT/GP74Km.
doi:10.1371/journal.ppat.1005755.g008
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Ectopic expression of GP129 and improved pathogenicity in animals
In an effort to determine if expression of the PC increased virus pathogenicity, comparative
animal studies were performed with different GPCMV: GP129FRT (group 1); SG GPCMV
(group 2); and NRD13, BAC derived GPCMV (group 3). Seronegative animals were randomly
divided into three groups (n = 12 per group) and animals were each inoculated with 106 pfu of
virus (either GP129FRT, SG GPCMV or NRD13 dependent on their specific group). At various
time points (4, 8, 12 and 27 days post infection), three animals per group were euthanized and
the viral load in target tissue and blood were determined by real time PCR as described in
materials and methods. The results of the viral pathogenicity study are shown in Fig 9. Statisti-
cal analysis (Student t test) was carried out for GP129FRT vs SG GPCMV and GP129FRT vs
NRD13 on tissue from similar target organs at similar time points. Overall, the GP129FRT
virus had a dissemination pattern that resembled SG GPCMV during the first 12 days of infec-
tion in target organs lung, liver and spleen (see Fig 9A–9C). The viral load in the salivary gland
was not evaluated until day 27 and was detected for both GP129FRT and SG GPCMV. The
viral load in the salivary gland was approximately 1 log higher for the SG GPCMV compared
to GP129FRT which was significant (p<0.005). Additionally, at day 27 the SG GPCMV could
be detected in the target organs lung, liver and spleen, whereas GP129FRT could only be
detected in the spleen. Overall, in the target organs there was a statistically significant differ-
ence (p<0.05 to<0.005) in viral load between GP129FRT and SG GPCMV except in the liver
(D4 and D8) and spleen at D4. Both SG GPCMV and GP129FRT exhibited similar viremia
Fig 9. GPCMV pathogenicity studies in seronegative animals. Comparative dissemination of viruses to target organs. Three separate
groups (n = 12 per group) of animals were infected with either SG GPCMV, GP129FRT or NRD13 viruses (106 pfu). At various days (4, 8,
12 and 27 days post infect infection, DPI), 3 animals per group were evaluated for viral load in target organs by real time PCR of tissue
extracted DNA. Viral load plotted as viral genome copies/mg tissue. Salivary gland tissue was only evaluated at day 27. Graph:A, lung; B,
liver; C, spleen;D, salivary gland. Blood viremia at 4, 8, 12 and 27 DPI is shown in E for viruses GP129FRT and SGGPCMV and plotted as
genome copies/ ml blood. Viremia for NRD13 was below the level of detection. Statistical analysis performed by Student t test comparing
viral load of GP129FRT vs SGGPCMV and GP129FRT vs NRD. Statistical groups: a) p <0.05; b) p < 0.005; c) NS non-significant.
doi:10.1371/journal.ppat.1005755.g009
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levels at days 4, 8 and 12 post infection, with peak levels detected at 8 days post infection. No
viremia was detected at day 27.
In contrast to GP129FRT and SG GPCMV, the parental BAC derived NRD13 virus (encod-
ing a truncated GP129) was highly attenuated in the animal model, see Fig 9. NRD13 was
detected in lung, liver spleen at days 4, 8 and 12 post infection but at substantially reduced lev-
els compared to GP129FRT and SG GPCMV. At all comparable time points, viral titer in all
NRD13 tissues were significantly lower with p< 0.005 when compared to GP129FRT (except
D4 lung and liver, p< 0.05). NRD13 failed to be detected in any target organs at day 27 and
was not present in the salivary gland. In contrast to the other viruses, NRD13 viremia at all
time points was below the level of detection (Fig 9E). Presumably, the inability of NRD13 to
form a pentameric complex and inability to infect a wider range of cell types precluded the abil-
ity of NRD13 to effectively disseminate or replicate in target organs. Overall, it was concluded
that restoration of an ability to express a missing full length GP129 protein resulted in a virus
that could not only infect epithelial cells in tissue culture but also had a greater pathogenicity in
the animal model compared to the parental GP129 mutant virus (NRD13). Importantly, the
GP129FRT virus was capable of disseminating to the salivary glands unlike the GP129 mutant.
Ectopic expression of GP129 and increased viral congenital infection
The placenta consists of both epithelial and endothelial cells, the improved tropism of the
GP129FRT virus for epithelial cells and other cell types in vivo could also potentially increase
the congenital transmission rate of the virus compared to the parental NRD13 virus. Seronega-
tive pregnant dams were challenged with 106 pfu of NRD13 (group 1, n = 8) or GP129FRT
(group 2, n = 11) at late second trimester via subcutaneous inoculation and animals were
allowed to go to term. The viral load in pup target organs (liver, lung, spleen, brain) of live or
still born animals was evaluated. Table 1 has the mortality outcome for live vs still born pups
for the groups. Table 2 has the viral load in the target organs of the pups (live and dead).There
was a higher number of still born pups in the GP129FRT group (9 pups, 17.3%) compared to
the NRD13 group (2 pups, 6.5%).
Overall, there was a greater incidence of organs positive for virus in the GP129FRT group
compared to the NRD13 group (p< 0.05). In the latter group, only the brain was detected posi-
tive for virus in one pup and all organs were negative in all other animals. In the GP129FRT
group, 20/52 pups had virus detected in various organs (brain, liver, spleen and lung). The
transmission rate for the GP129FRT virus was 38.46% compared to 3.2% for the NRD13 virus,
which was statistically significant (p = 0.0002). It should be noted that none of the still born
pups in the NRD13 group were positive for virus and their death in utero was likely a complica-
tion of pregnancy and not associated with congenital CMV infection.
Only a limited number of term placentas were available for evaluation of viral load (2 for
GP129FRT group and 7 for NRD13 group) but only the GP129FRT infected animals had
CMV positive placentas (see Table 2). The presence of GP129FRT virus in the placenta (3rd tri-
mester) of an additional pregnant guinea pig was evaluated by immunohistochemistry at day
Table 1. Congenital CMV pup birth outcome.
Groups n Litters # pups
Total Live only Dead only Mixed Reabsorbed Live/ dead %mortality
NRD13 8 7 6 0 1 1 29/2a 6.5%
GP129FRT 11 10 5 0 5 1 43/9a 17.3%
ap = non-signiﬁcant (Fisher’s exact test)
doi:10.1371/journal.ppat.1005755.t001
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22 post-infection. Fig 10 shows the results for immunohistochemistry staining of cryostat sec-
tions of placenta for GPCMV gB antigens. The presence of virus in placenta tissue was also ver-
ified by DNA extraction and PCR. Fig 10 Panel A shows a cartoon of the placenta structure
and indicated regions where viral antigen was detected in cryostat sections (C and D). Panel B
shows an agarose gel PCR analysis for DNA extracted from virus infected epithelial cells or pla-
centa section. The PCR was for the GP128-GP133 locus and only a full length locus (2 kb) was
detected. Panels C and D are sections stained for GPCMV gB protein. Representative control
Table 2. Congenital CMV infection viral load in pups and transmission rate.
Groups CMV+ pups Lunga Livera Spleena Braina Placentaa
NRD13 1/31 (3.22%) 0 (0/31) 0 (0/31) 0 (0/31) 1.50x103 (1/31) (0/7)
GP129FRT 20/52 (38.46%) 4.65x102 (15/52) 5.19x102 (10/52) 1.53x102 (12/52) 1.56x103 (10/52) 4.36x103 (2/2)
P value 0.0002b 0.0006c 0.011c 0.0028c 0.047c 0.028c
aViral load expressed in CMV copies/mg tissue (No. of CMV+/total tissue sample)
bTransmission rate (GPCMV detected in at least one organ) Fisher’s exact test
cComparison of CMV+ samples in each tissue group GP129FRT vs NRD13 (Fisher’s exact test)
doi:10.1371/journal.ppat.1005755.t002
Fig 10. Detection of GP129FRT in guinea pig placenta. Placentas were collected from a euthanized
pregnant (3rd trimester) Hartley guinea pig at 22 days post infection with GPCMV129FRT (10^6 pfu
subcutaneous injection). Immunohistochemistry was performed on frozen cryostat sections (5 um) as
described in materials and methods and stained for GPCMV gB glycoprotein. A. Cartoon of the guinea pig
placenta (based on ref [20]). C and D indicate the location of the gB antigen detected (labyrinth) in panels C
and D. B. Agarose gel of theGP128-133 locus PCR amplified from DNA extracted from EPI cells or placenta
tissue with P1 and P2 primers (Fig 1). Left lane SGGPCMV (epi cells) and right lane GP129FRT (placenta).
C andD. Immunohistochemistry stain of placenta tissue for GPCMV gB. E and F. Control immunochemistry
placenta sections (secondary antibody only).
doi:10.1371/journal.ppat.1005755.g010
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sections (no primary antibody) are shown in panels E and F. Virus was mainly detected in the
interface of the labyrinth region of the placenta. These results confirm the presence of viral
antigens in the placenta. We concluded that the GPCMV congenital transmission rate was
highly dependent upon the virus encoding a functional GP129/ PC. A wider range of virus cell
tropism would presumably be a requirement for effective congenital transmission to the fetus
since the maternal fetal barrier in the placenta consists of a layer of epithelial syncytiotropho-
blast cells [99, 100].
Discussion
Electron microscopy histopathology studies of guinea pig salivary gland (duct cells) and pla-
cental tissue (trophoblast cells) from GPCMV infected animals suggested that GPCMV can
infect epithelial cells [21, 101]. Retrospectively, these were important observations in the con-
text of viral tropism and recent identification of a novel mechanism of HCMV infection of epi-
thelial and endothelial cells and other cell types [60, 61, 63, 64]. Our recent knockout
mutagenesis studies of GPCMV glycoprotein genes (encoding homologs of gB, gH, gL, gO,
gM, or gN) demonstrated a conservation of essential function and homolog glycoprotein com-
plex formation (gB, gH/gL/gO and gM/gN) between HCMV and GPCMV [36, 102]. This pres-
ent study demonstrated that the UL128-131 homolog locus (GP129-GP133) [28] was necessary
for GPCMV infection of guinea epithelial cells in tissue culture and that tropism is dependent
upon the ability to form a pentameric homolog complex which is structurally present in the
viral particle. GPCMV knockout mutagenesis demonstrated that pentameric complex forma-
tion and epithelial tropism was dependent upon an ability of the virus to express wild type
GP129, GP131 and GP133 but that GP128 was non-essential for complex formation, nor epi-
thelial tropism. Furthermore, improved epithelial tropism, pathogenicity and congenital infec-
tion in the animal model could be established for a mutant virus (GP129mutant in the GP128-
133 locus) via ectopic expression of a wild type GP129 cDNA and subsequent ability to form a
homolog pentameric complex. Importantly, GPCMV pentameric complex formation is dis-
pensable for infection of fibroblast cells, as is the case for HCMV. Curiously, Auerbach et al.
[90] showed an enhancement of GPCMV fibroblast infection associated with a full length
GP129-133 locus. Our studies with both GPL fibroblast cells and in house primary fetal embryo
fibroblasts did not determine a dependence upon an intact GP128-133 locus for fibroblast virus
infection. Similarly, Inoue and colleagues [26] did not see PC dependence for infection of pri-
mary or immortalized guinea pig fibroblast cells [28]. Surprisingly, Auerbach and colleagues
failed to demonstrate a specific tropism for endothelial cells in virus with an intact GP128-133
locus compared to virus with a deletion in that locus [90]. Based on our epithelial tropism data
and in vivo pathogenicity studies, the prediction would be that PC positive GPCMV would
exhibit increased tropism to a wider range of cell types. This increased range would include
endothelial cells. HCMV exhibits the same requirement for the PC for cell entry in both epithe-
lial and endothelial cells [63, 64]. In addition to the current reported epithelial cell line, we
have recently isolated two guinea pig placenta derived epithelial cell lines which have the same
stringency of requirement for the GPCMV pentameric complex [103]. Importantly, studies on
guinea pig leukocyte cells suggest that the PC is necessary for infection on these cell types,
which is a similar requirement as seen for HCMV [93, 104].
Potentially, in the Auerbach et al. study [90], the endothelial cell population, which were
isolated by flow cytometry using cross reacting antibodies, there was a low level of contaminat-
ing fibroblast cells, which would prevent a contrasting requirement for the pentameric complex
for cellular infection. In our study, epithelial cell isolation was carried out by conventional clon-
ing strategy and antibody staining of cells for cytokeratin marker. Additionally, the
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immortalized cell lines were re-cloned and characterized (S3 Fig). In contrast, Auerbach et al.
[90], elected to employ RT-PCR analysis of total cell monolayer lysate to characterize their pri-
mary endothelial cells despite von Willebrand factor antibody being successfully used to iden-
tify guinea pig endothelial cells in previous studies [105]. Consequently, the uniformity of their
endothelial cell line remains to be fully confirmed. Importantly, newly isolated epithelial cell
lines from the guinea pig placenta demonstrate that GPCMV infection of specialized placental
cells requires the PC [103] which further supports the hypothesis that increased congenital
transmission is PC dependent. This also explains the increased congenital infection rate
observed in virus encoding the full length GP128-133 locus [29, 106].
Transient expression of the homolog components of the penatmeric complex (gH, gL,
UL129, UL131, UL133) in epithelial cells resulted in complex formation in the absence of other
viral components and this confirmed the results by Auerbach et al. [90] which used purified
recombinant baculovirus expressed protein to form pentameric complex in vitro. Importantly,
a natural C-terminal deletion mutant of the GP129 protein (codons 102–179) from a virus
lacking epithelial tropism (NRD13) was incapable to forming a pentameric complex with other
complex components. The importance of C-terminal domain of GP129 for stable PC forma-
tion in recombinant GPCMV remains to be further evaluated.
In this current report, PC mutant studies were limited to GP129 but the generation of
mutants of other PC components (eg. GP131 or GP133) would be worth evaluation in future
studies to aid in the definition of critical domains for complex formation. In HCMV, the
UL128 protein interaction with gH/gL is a potentially important key stage because of disul-
phide bond formation with gL [55]. In our GPCMV studies, we demonstrated that interactions
with gL as well as gH is important for PC formation (Fig 2 and S7 Fig). Additionally, gH/gL/
GP129 triplex complexes occur (Fig 4), but disulphide bond formation was not investigated.
Most certainly, conservation of cysteine amino acids means that the GP129 has the possibility
of interacting with gL in the same specific manner. Importantly, the GP129 mutant was unable
to form a triplex complex with gH/gL. Triplex complexes with gH/gL and GP131 or GP133
could also be demonstrated. Subcomplex formation has been demonstrated to occur for
HCMV between various components of the PC [62]. An evaluation of the stoichiometry of
these subcomplexes in various cell types might be important in the determination of their influ-
ence on the immune response of the host. The GPCMV PC is highly immunogenic but not
individual unique components (GP129, GP131 or GP133) based on newly developed ELISA
assays [103]. Consequently, the homolog PC would appear an important target antigen in
GPCMV as is the case for the PC in HCMV.
A fundamental question is what dictates formation of a gH/gL/gO triplex, or gH/gL/UL128-
131 pentamer in HCMV, and the homolog complexes in GPCMV infected cells. In GPCMV,
GP129, GP131 and GP133 would have a theoretical 3:1 advantage over gO for interaction with
gH/gL and the same would be the case for HCMV (UL128, UL130 and UL131). In a recent
model for HCMV pentamer complex formation, Ciferri et al [55] proposed that UL128 and gO
each compete to form a disulphide bond with gL at codon 144 in an exclusive way in the gH/gL
complex and that this is the most important interaction since UL130 and UL131 attach to gH/
gL via non-covalent bonds. Alternatively, in HCMV an additional protein encoded in the ULb’
region (UL148) has been proposed to regulate gH/gL/gO or gH/gL pentamer formation in an
undefined manner [107]. Identification of a homolog UL148 might be worthwhile exploring in
future GPCMV studies as would evaluation of the ability of GP129 to bind gH/gL competitively
in the presence of gO.
Curiously, gO in human and animal CMV is heavily N-glycosylated. In a previous publica-
tion [36], we investigated the importance of the N-glycosylated or non-glycosylated gO protein
in GPCMV gH/gL/gO triplex formation. Both wild type (N-glycosylated) gO and a gO mutant
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(lacking N-glycosylation sites) were equally capable of forming a triplex. Additionally, in GPL
cells infected with GPCMV, the wild type gO could be detected as both glycosylated and non-
glycosylated in equal amounts but in transient plasmid expression studies only the N-glycosy-
lated gO could be detected [36]. Potentially, the gO glycosylation state could have ramifications
for the steady state of gH/gL available to interact with pentameric complex components. A
heavily N-glycosylated gO protein may have a more effective interaction with the endoplasmic
reticulum (ER) calnexin chaperone protein system [108]. This in turn may enhance the move-
ment of gO or gH/gL/gO complex through the ER resulting in more efficient virion maturation
and egress. Consequently, if the glycosylation status of gO in fibroblast vs epithelial cells was
different then potentially this might influence the ability of one complex to form over another
and subsequently augment viral tropism by the variation of triplex vs pentameric complex on
the outside of the viral particle. However, to more fully investigate these possibilities in
GPCMV would require the development of a gO specific antibody for full evaluation of these
effects.
The animal pathogenicity studies demonstrated that a restoration of an ability of the virus
to form a pentameric complex not only resulted in epithelial tropism but also increased viral
pathogenicity as well as congenital transmission rate (Fig 9, Tables 1 and 2). The ectopic
expression of GP129 cDNA resulted in a virus with similar pathogenicity pattern to SG
GPCMV and importantly the virus reached the salivary glands. In contrast, the parental
GPCMV BAC derived virus (NRD13) lacked viremia and poorly disseminated. Additionally,
the GP129FRT virus had a congenital transmission rate of 38.4% compared to 3.2% for
NRD13. Congenital GPCMV challenge studies are normally carried out with virus stock gener-
ated by serial passage in the animal and virus generated as salivary gland stock. The SG
GPCMV stock of wild type virus has a congenital transmission rate between 55–75% based on
previous publications. Potentially, passage of GP129FRT in animals to generate a salivary
gland stock might be enhance the congenital rate of the virus and these studies are currently
underway.
The basis for the viral attenuation occurring in fibroblast cells (GP128-133 locus mutation)
is undetermined. Most certainly there appears to be a bias in fibroblast cells for the production
of cell free virus encoding the triplex compared to virus that also encodes the pentameric com-
plex. The spliced nature of the encoded GP129 and GP131 genes might be a contributing factor
to a rate limiting step on expression kinetics. Alternatively, the gO glycosylation status in fibro-
blast cells compared to epithelial or other cell types might influence triplex (gH/gL/gO) forma-
tion. Overall, these factors might also be a basis for the rapid generation of GP128-133 locus
mutants when SG GPCMV is serially passaged on fibroblast cells. However, this remains to be
further investigated and may potentially require the development of additional epithelial and
fibroblast cell lines to demonstrate that this phenomenon is not limited to the cell lines used in
this study.
In summary, this study demonstrated that the UL128-131 homolog locus (GP129-GP133) is
necessary for GPCMV to form a homolog PC. Additionally, loss by GPCMV of the capability
to form the PC impaired epithelial cell tropism and attenuated the virus in the animal model.
Importantly, restoration of GPCMV epithelial tropism resulted in increased pathogenicity and
congenital transmission rates. Overall, these findings strengthen the guinea pig as a highly rele-
vant model for HCMV congenital infection and the development of CMV vaccine or interven-
tion strategies against congenital infection. Additionally, these studies emphasize the
importance of the PC for congenital transmission and strongly suggest that a vaccine aimed at
preventing congenital infection should incorporate the pentameric complex as part of a vaccine
design.
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Materials and Methods
Cells, viruses and oligonucleotides
GPCMV (strain 22122, ATCC VR682), first and second generation GPCMV BAC [26, 27]
derived viruses were propagated on guinea pig fibroblast lung cells (GPL; ATCC CCL 158) in
F-12 medium supplemented with 10% fetal calf serum (FCS, Life Technologies), 10,000 IU of
penicillin/liter, 10 mg of streptomycin/liter (Life Technologies), and 7.5% NaHCO3 (Life Tech-
nologies) at 37°C/5% CO2. Virus titrations were carried out on six-well plates. Plaques were
stained with 10% Giemsa stain or visualized by fluorescence microscopy. High titer stock
viruses were generated as previously described [36]. Sucrose gradient purified stocks were ini-
tially generated as high titer stock virus and subsequently purified on a sucrose gradient follow-
ing a previously described protocol [109]. Guinea pig epithelial cells were initially isolated as
primary renal epithelial tubule cells from the kidney of a Hartley guinea pig by conventional
clonal ring procedure. Primary epithelial cells were initially maintained on collagen (Life Tech-
nologies) coated plates in epithelial cell growth media (Applied Technology) supplemented
with 10% FCS (Life Technologies) and antibiotics as described for F-12 media. Transformed
epithelial cells were maintained in high glucose DMEM with sodium pyruvate (Life Technolo-
gies) supplemented with 5% FCS (Life Technologies) and antibiotics as described for F-12
media. Epithelial cells were maintained at 37°C/5% CO2 and characterized as epithelial cells by
characteristic cobbled stone appearance of the cell monolayer as well as staining positive for
cytokeratin marker (anti-pancytokeratin antibody and anti-cytokeratin 18 antibody, Cell Sig-
naling). Tissue culture stocks of GP129FRT and SG GPCMV were generated on epithelial cells.
All oligonucleotides were synthesized by Sigma-Genosys (The Woodlands, TX) and are listed
in S1 Table.
Transformed guinea pig renal epithelial cells
Primary Hartley guinea pig renal epithelial cells were isolated following protocol by [110]. Sub-
sequently, cells were transformed by transduction with defective lentiviruses encoding SV40
TAg or HPV E6/E7 (Applied Biological Materials Inc.) following manufacturer’s protocol.
Cells were re-seeded onto collagen coated 100mm dishes and propagated in high glucose
DMEM with sodium pyruvate (Invitrogen) supplemented with 10% fetal calf serum and 1X
antibiotic-antimycotic (Life Technologies) and 37°C/5% CO2. Rapidly growing colonies were
isolated by clonal ring procedure and subcloned onto fresh monolayers of collagen coated
plates and maintained as separate cell lines and aliquots of cells in cryopreserve media (Gemini
Bioproducts) and stored in liquid nitrogen. Transformed cells were verified as epithelial by pos-
itive staining for cytokeratin marker by western blot or immunofluorescent staining using anti-
pancytokeratin (Cell Signaling Technology) and anti-cytokeratin 19 (Applied Technology)
using a previously described protocol [36]. SV40 T antigen transformed cells were poorly sup-
portive of GPCMV infection and were not used in the reported studies. HPV E6/E7 trans-
formed cells were supportive of GPCMV infection and used extensively in the studies.
Ethics
Guinea pig (Hartley) animal studies were carried out under approval by IACUC at Texas A&M
University, permit 2013#013. All study procedures were carried out in strict accordance with
the recommendations in the “Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health.” Animals were observed daily by trained animal care staff, and
animals requiring care were referred to the attending veterinarian for immediate care or eutha-
nasia. Terminal euthanasia was carried out by lethal CO2 overdose followed by cervical
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dislocation in accordance with IACUC protocol and NIH guidelines. Animals purchased from
Charles River Laboratories were verified as seronegative for GPCMV by toe nail clip bleed and
anti-GPCMV ELISA of sera as previously described [36].
Pathogenicity studies. Seronegative animals were randomly divided into three groups (n = 12
per group): GP129FRT (group 1); SG GPCMV (group 2); and NRD13, BAC derived GPCMV
(group 3). Animals were each inoculated with 106 pfu of virus via subcutaneous injection (either
GP129FRT, SG GPCMV or NRD13, dependent on their specific group). At various time points (4,
8, 12 and 27 days post infection), two animals per group were euthanized and the viral load in target
tissue (liver, lung, spleen, salivary glands) and blood were determined by real time PCR.
Congenital GPCMV study. Seronegative pregnant dams were challenged with 106 pfu of
NRD13 (group 1, n = 8) or GP129FRT (group 2, n = 11) at late second trimester via subcutane-
ous inoculation and animals were allowed to go to term. The viral load in target organs (liver,
lung, spleen, brain) of live or still born pups was evaluated by real time PCR. Additionally, for
immunohistochemistry studies of infected placenta, a single pregnant dam was challenged
with GP129FRT as described above. At 22 days post infection, the dam was euthanized and
placenta recovered for evaluation of virus infection via immunohistochemical staining. Frozen
placenta was sectioned using a cryostat (5 um thickness). Sections were fixed and analyzed for
the presence of GPCMV using mouse anti-gB antibody (29:29) and anti-mouse IgG elite ABC
kit (Vectastain) following manufacturer’s protocol.
Real time PCR
Blood and tissues (lung, liver, spleen) were collected from euthanized guinea pigs to determine
the viral load. For pups from congenital infection studies, blood and tissues (lung, liver, spleen,
brain) were collected within 3 days post birth. Pup specific placenta was collected and preserved
for DNA extraction when applicable. For tissue DNA extraction, FastPrep 24 (MP Biomedical)
was used to homogenize tissues as a 20% weight/volume homogenate in Lysing Matrix D (MP
Biomedicals). To obtain DNA from whole blood, 500ul of blood was collected (by toe nail clip
bleed) into tubes containing ACD anticoagulant and 200μl of blood was subsequently used per
extraction. DNA was extracted using the QIAxtractor (Qiagen) according to manufacturer’s liq-
uid (blood) or tissue protocol instructions. Viral load was determined by real time PCR on Light-
cycler 480 (Roche Applied Science). Primers and hydrolysis probe were designed using the
Lightcycler Probe Design2 program to amplify a product from the GPCMVGP44 gene: Forward
primer 5’TCTCCACGGTGAAAGAGTTGT; Reverse primer 5’GTGCTGTCGGACCACGATA;
hydrolysis probe 5’FAM-TCTTGCTCTGCAGGTGGACGA-BHQ1. PCRmaster mix contained
Lightcycler Probes Master (Roche Life Science), 0.4 μMprimers and 0.1 μMprobe, 0.4U uracil
N-glycosylase (UNG) in 25μl total reaction volume including 10 μl of DNA per reaction. Stan-
dard controls and no template controls (NTC) were run with each assay for quantification. Light-
cycler480 amplification parameters were: UNG step for 10 minutes at 40°C followed by
activation at 95°C for 10 minutes, then 45 cycles of denaturation at 95°C for 15s, annealing at
56°C for 15s, elongation at 72°C for 10s. Data was collected by ‘single’ acquisition during the
extension step. Standard curve was generated using GPCMVGP44 plasmid [33] for quantifica-
tion and assay sensitivity. The sensitivity of the assay was determined to be 5 copies /reaction.
Viral load was expressed as copy number/ml of blood or copy number/mg tissue. Results calcu-
lated were a mean value of triplicate PCR runs per sample.
Cloning of GPCMV genes and generation of knockout shuttle vectors
The predicted GPCMV coding sequences were based on the complete 22122 viral genome
sequence (Genbank accession #AB592928.1). The specific gene coding sequence co-ordinates
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are: GP74, gO, (117,992–119,104); GP75, gH, (119,553–121,724); GP115, gL, (180,216–
180,992); GP128 (195,713–196,768); GP129 complement (196,745–197,003; 197,081–197,206;
197,285–197,439); GP131 complement (197,444–197,780; 197,861–198,102); GP133 comple-
ment (198,102–198485) and GP130 (196,968–197360). Generation of individual shuttle vectors
for specific gene knockout (or intergenic insertion of GP129) and construction of transient
expression vectors are described in more detail below.
GP128-GP133 locus knockout shuttle vectors. In order to carry out a systematic knock-
out of the GPCMV genes (GP129, GP131 and GP133), synthetic gene sequences were generated
with unique flanking homologous regions for recombination with the GPCMV genome
sequence that also introduced targeted deletion of the majority of the specific gene of interest.
Two synthetic shuttle vectors pSYDGP129/131 (GPCMV flanking sequence 197,041–197,291;
198,091–198,300) and pSYDGP133 (GPCMV flanking sequence 198,178–198,360; 198,490–
198720) were generated (DNA2.0) to knockout GP129 and GP131 or GP133 respectively.
pSYDGP129/131 targeted deletion of GPCMV nucleotides 197,292–198090 (798 base
deletion). pSYDGP133 targeted deletion of GPCMV nucleotides 198,361–198,489 (138 base
deletion). The shuttle vectors were engineered to carry a BamH I site in the deleted locus. Sub-
sequently the shuttle vectors were modified by insertion of a kanamycin/FRT cassette [36] into
the unique BamHI site between left and right flanking arms of the respective shuttle vectors to
generate pSYDGP129/131KmFRT and pSYDGP133KmFRT. For GP128 knockout, the com-
plete coding sequence was PCR amplified as a BamHI fragment with the primer set GP128F
and GP128R (S1 table) and cloned into pUC19 to generate pUCGP128Bm. A kanamycin/FRT
cassette with flanking EcoR V sites was cloned into a unique EcoR V site within the GP128 cod-
ing sequence to disrupt the ORF at codon 176 (pGP128KmFRTEcV). S1 Fig shows the location
of the GPCMV sequence modifications in the GP128-GP133 locus.
GP25/GP26 locus shuttle vector. For ectopic expression of GP129myc, the ORF was
placed under SV40 promoter control, a shuttle vector was generated that introduced a cassette
into an intergenic locus between GP25 and GP26. This locus was selected as both genes co-ter-
minate in this locus from opposite directions and insertion into this intergenic locus has previ-
ously been shown not to impact on the virus growth kinetics [25]. First the GP25/GP26 locus
(GPCMV (strain 22122) 37,672–38,953bases) was PCR amplified as an EcoR I to Hind III frag-
ment partially encoding GP25 and GP26 using primers FGP25 and RGP26 (S1 Table) and
cloned into pUC19 as an EcoR I/ Hind III fragment to generate pUCGP25/GP26 (S11 Fig).
Next, the SV40 promoter/ SV40 polyA sequence from pSI (Promega) was isolated as a Bgl II/
BamH I fragment and cloned into the unique BamH I site (GPCMV 22122 strain, position
38,538 bases) in the intergenic locus between GP25 (sense strand) and GP26 (complementary
strand) genes in linearized pUCGP25/GP26 to generate pSIGP25/GP26. A synthetic intron
was removed from the shuttle vector by Pst I/Sal I collapse of the polylinker and insertion of a
50 bp linker sequence (Link1, see S1 Table) to generate pGP25/26Link1 which now carried
unique Bgl II and BamH I sites. A BamH I fragment of GP129myc was cloned into Bgl II cut
pGP2526Link1 to generate pGP129Link1. Subsequently, a BamH I Km cassette [36] flanked by
FRT sites was cloned into pGP129link cut with BamH I to generate pGP129limkKmFRT
which was the final recombination shuttle vector expressing GP129. The nucleotide sequence
of the GP25/GP26 locus and the cloning strategy for generation of the recombination shuttle
vector and locus modifications are shown in S10 Fig and S11 Fig.
Construction of GPCMV gH, gL and GP128 tagged mammalian expression vectors.
The gH (GP75), gL (GP115) and gO (GP74) ORFs were additionally separately cloned into
expression vectors that also tagged the C-terminal domain for easy detection of the recombi-
nant protein in transfected cells. For GFP tagged gH, the GP75 ORF (missing the stop codon)
was PCR amplified as a BamH I fragment using primers FgHBm and RgHBmNostop (S1
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Table) and cloned inframe into GFP fusion expression vector pAcGFP-N1 (Clontech) cut with
BamH I. This introduced a GFP tag in-frame into the C-terminal domain of the gH ORF and
placed the GP75 under a HCMVMIE promoter control. This modified plasmid was designated
pAcGFPNgH. For mCherry tagged gL, the GP115 ORF (missing the stop codon) was PCR
amplified as aHind III fragment using primers FgLHd and RgLHdNostop (S1 Table) and
cloned inframe into mCherry fusion expression vector pmCherry-N1 (Clontech) cut with
Hind III. This introduced a mCherry tag in-frame into the C-terminal domain of the gL ORF
and placed the GP115 under a HCMVMIE promoter control. This modified plasmid was des-
ignated pmCherryNgL. A GP128 FLAG tagged vector was generated by PCR using the primer
set GP128F and GP128R (S1 Table) cloned as a BamH I fragment into pCMV3Tag (Agilent
Technology). The GP128 ORF PCR lacked a stop codon and the BamH I site enabled inframe
cloning that introduced a 3xFLAG tag into the C-terminus of GP128 (pFLAGGP128).
GP129, GP130, GP131 and GP133 tagged mammalian expression vectors. C-terminal
epitope tagged versions of GP129 (3xmyc), GP131 (3xHA), GP133 (3xFLAG) and GP130
(3xFLAG) cDNAs were generated as synthetic genes (DNA2.0 Inc.) based on the defined cod-
ing sequence GenBank: KC503762.1 AB592928.1 and cloned under HCMVMIE promoter
control in a high copy plasmid vector (pJ603, DNA2.0 Inc).
GP129 C-terminal mutants. A synthetic GP129 ORF was generated for the natural trun-
cated C-terminal mutant NRD13 (codon 102–179 deleted). A HCMV chimeric GP129/UL128
C-terminal mutant was also generated that encoded the terminal 48 codons of HCMV (Merlin
strain) UL128 in place of codons 128–179 of GP129. Both GP129 mutants were myc tagged.
Generation of gene knockout GPCMV BACmids and analysis of
GPCMV BACmutants
An inducible ET recombination system (GeneBridges) was introduced into DH10B bacterial
cells containing a second generation GPCMV BAC plasmid [26, 27] using a protocol previ-
ously described [32]. Individual GPCMV gene knockout targeting shuttle vectors were line-
arized with a unique restriction enzyme cutting outside the target gene flanking sequence.
Linearized DNA plasmids or PCR products were band isolated and concentrations of DNA
were modified to introduce 1μg of linear DNA into each transformation reaction via electro-
poration [32]. Recombinant bacterial colonies of GPCMV BAC mutants were isolated by
chloramphenicol (12.5 μg/ml) and kanamycin (20 μg/ml) antibiotic selection in LB agar bac-
terial Petri dishes. Bacterial plates were initially incubated at 39°C to remove the ts ET
recombination plasmid (Genebridges). Mutant GPCMV BAC DNA was purified by maxi-
prep kit (Qiagen) and analyzed by separate EcoR I and Hind III restriction digestions to ver-
ify the accuracy of the predicted genome configuration after mutation [26, 27]. Insertion of
the kanamycin (Km) drug resistance cassette into the viral genome introduced a novel Hind
III restriction enzyme site at the site of mutation to enable verification of locus modification.
Specific gene modifications were confirmed by comparative PCR analysis between wild type
and mutant GPCMV BACs using common flanking primers. The gene knockout for mutants
was further verified by sequencing of the PCR product. In order to enable a second round of
GPCMV BAC mutagenesis, the original Km cassette inserted into the genome was removed
by FLP recombinase strategy if the Km cassette was flanked by FRT sites. The FLP recombi-
nation was accomplished by transforming the BAC positive bacteria with a FLP expression
suicide plasmid (p707, GeneBridges) (permissive conditions with tetracycline (3ug/ml) at
31°C) and recombinase induction and excision of the FRTKm cassette accomplished follow-
ing manufacturer’s protocol. A second round of recombination could then be carried out on
the GPCMV BAC as described above.
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GPCMV BACmutagenesis and characterization of results
GPCMV genes GP128, GP129, GP131 and GP133 were individually knocked out by targeted
mutagenesis of the GPCMV BAC in bacteria using shuttle vectors carrying a Km drug resis-
tance marker to disrupt each ORF. Targeted recombination knockout of GPCMV genes was
performed in the second generation GPCMV BAC [27]. Fig 1 shows the layout of the GP128-
133 locus. S1 Fig shows the annotated nucleotide sequence of the GP128-133 locus with the
location of the genes shaded and the specific deletions introduced for GP129-GP131 or GP133
mutants indicated. The GP129/GP131mutant was generated with a BamHI FRT Km insertion
between flanking sequence on the synthetic deletion shuttle pSYDGP129/131, which deleted
GPCMV nucleotides 197,292–198,090 (798 bp deletion within the GP129-GP131 coding
sequence, see S1 Fig). The GP133mutant was generated by a BamH I FRT Km insertion
between flanking sequence on the synthetic deletion shuttle vector pSYDGP133, which deleted
GPCMV nucleotides 198,361–198,489 (138 base deletion which included the GP133 start
codon (S1 Fig). The GP128 gene was modified by insertion of a EcoR V FRT Km cassette at a
unique EcoR V site (GPCMV nucleotide 196,234) in the GP128 gene of the GP128 shuttle vec-
tor (pGP128KmFRTEcV), which disrupted the GP128 ORF at codon 176. The mutant
GPCMV BACs were analyzed by restriction enzyme profile analysis as previously described
[36]. Insertion of the Km drug resistance cassette into the viral genome introduced a novel
Hind III restriction enzyme site at the site of mutation to enable verification of locus modifica-
tion. Modified GPCMV genomes were analyzed separately by EcoR I andHind III restriction
enzyme profile analysis. In an effort to limit redundancy the profiles shown for each mutant
are either Hind III or EcoR I analysis. Additionally, two clonal mutants were generated for each
knockout but only one is described. Comparative restriction fragment profiles of wild type and
mutant GPCMV BAC genomes correctly demonstrated specific sub-genomic fragment modifi-
cation for all mutants. Designated GPCMV restriction fragment band nomenclature described
by Gao and Isom [111] was used to identify specific band shifts, except that the 5’ and 3’
genome terminal ends were considered linked in a covalent closed circle [26]. S12 Fig shows
the GP128mutant EcoR I profile andHind III profiles for GP129-131 and GP133mutants com-
pared to the wt GPCMV BAC profiles. Specific gene locus modifications were further verified
by PCR analysis and sequencing as previously described [36]. The GP128 gene encoded in the
4.9 kb EcoR I GPCMV genomic fragment (192,215–197,167) was modified in the GP128
mutant by insertion of the 1.1 kb Km cassette which shifted the fragment to 6 kb (S12 Fig). The
GP129, GP131 and GP133 genes are encoded in the 19.7 kbHind III GPCMV genomic frag-
ment and targeted knockout of these genes introduced a new Hind III site encoded in the
inserted Kmmarker. The GP129-GP131 deletion mutant Hind III fragment was modified
from 19.7 kb to 5 kb and approximately 15 kb (S12 Fig). In the GP133 deletion mutant the 19.7
kbHind III GPCMV genomic fragment was modified to 6 kb and 14.9 kb fragments (S12 Fig).
Mutant GPCMV BACs were independently subject to an additional round of mutagenesis
to introduce a wild type GP129 (myc tagged) cDNA into the GP25/26 intergenic locus under
SV40 promoter control as described in an earlier section for ectopic expression of GP129. This
required excision of the Km FRT cassette from the originally mutated locus by Flp recombinase
as described (see above section). Excision of the Km cassette was confirmed by patching of col-
onies for the loss antibiotic resistance and the integrity of the GPCMV BAC confirmed by
restriction profile analysis (S12 Fig). GPCMV BACs retained a FRT site at the original site of
excision. E.coli (DH10B) cells carrying respective GPCMV BAC mutants underwent ET
recombination induction and targeted modification with the shuttle vector
pGP129limkKmFRT as previously described. GP25/GP26 locus mutants (carrying GP129myc
cDNA) were isolated by Kmmarker insertion as previously described. Full length GPCMV
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BAC clones were identified by EcoR I restriction profile analysis (S12 Fig) and subsequently
confirmed by PCR of the GP25/GP26 locus and sequencing (S11 Fig). Mutants carrying GP129
cDNA in the GP25/GP26 locus were designated: (1) GP129FRT (wt GPCMV BAC); (2)
GP128FRT/GP129Link (GP128mutant); (3) GP129-GP131FRT/ GP129Link (GP129-GP131
deletion mutant); (4) GP133FRT/GP129Link (GP133 deletion mutant). In regard to the ectopic
insertion of a GP129 cDNA into the GP25/GP26 intergenic locus, the modification generated a
characteristic altered GPCMV EcoR I profile. The 5.2 kb GPCMV EcoR I genomic fragment
(nucleotides 35,537–40,739) containing the GP25/GP26 locus was modified by the insertion of
the SV40 promoter /GP129 expression cassette/SV40 polyA sequence and Kmmarker into the
BamH I site (nucleotide 38,538). The modified sequence also introduced two novel EcoR I
sites. As predicted the original 5.2 kb genomic fragment was modified to two novel fragments
(3.5 and 3.9 kb). S12 Fig shows the modified profiles for wt GPCMV, GP128 and GP129-131
mutants (GP128FRT/GP129Link and GP129-GP131FRT/ GP129Link respectively) but not the
GP133 mutant to limit redundancy. An additional GPCMV BAC mutant was engineered into
GP129FRT GPCMV BAC which introduced a Km cassette into the GP74 gene (glycoprotein
gO) as previously described [36]. This generated a GPCMV BAC mutant that encoded a
GP129 cDNA in the GP25/26 locus (Km replaced by FRT sites only) and a GP74 knockout by
insertion of a Km cassette which disrupted the ORF at codon 110 [36] (double mutant was des-
ignated GP129FRT/GP74Km). The GP74mutation was confirmed by EcoR I profile analysis of
the GPCMV BAC genome. The original 18 kb EcoR I genomic fragment (nucleotides 102,796–
120,821) that encoded the GP74 locus was increased in size by 1.1 kb by the insertion of a Km
cassette which modified the size of the fragment to 19.1 kb, see S12 Fig.
The gB (GP55) knockout mutant was generated on the backdrop of GP129FRT GPCMV
BAC. The GP55 gene (94,164–96,869) was knocked out by insertion of a Km cassette which
disrupted the ORF at codon 528 as previously described [36]. The insertion of the Km cassette
modified the size of the 4470 EcoR I subgenomic fragment (91,190–95,659) by approximately 1
kb generating a novel EcoR I restriction fragment of approximately 5.5 kb on the GP129FRT/
GP55km GPCMV BAC EcoR I profile. The positions of the wild type and mutant EcoR I
restriction fragments are indicated in S12(vii) Fig.
Generation of mutant GPCMV
For generation of recombinant viruses, large-scale GPCMV BAC DNA was purified from E.
coli DH10B strain using a maxi plasmid kit (Qiagen). BAC DNA was transfected onto GPL
cells in six well dishes using Lipofectamine 2000 (Invitrogen) as previously described [33].
GPCMV BAC transfections were carried out with two independent clones for each gene
knockout. Transfections were followed for at least 3–4 weeks for the production of viral pla-
ques. GFP positive viral plaques were detected via microscopy [33]. Non-infectious mutants
produced only single GFP positive cells that did not progress to viral plaques. GPCMVmutant
BAC transfections were carried out multiple times (minimum of 6 times) for each clone. Exci-
sion of the BAC plasmid from recombinant viral genome was carried out by co-transfection of
BAC DNA with plasmid encoding CRE recombinase (pCRE), a generous gift from Dr. Mike
McVoy (Virginia Commonwealth University). Cre BAC excised virus also lost the GFP
reporter cassette encoded on the BAC plasmid and therefore GFP negative plaques confirmed
successful BAC plasmid excision. Large scale virus stocks were generated as previously
described [33] and additionally epitropic viruses were generated as virus stocks on epithelial
cells following the same procedure. A gB knockout (GP129FRT/GP55km) rescue virus was
generated by co-transfection of GP129FRT/GP55km BAC with GP55 rescue plasmid as previ-
ously described [36].
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Recombinant adenovirus vectors
Recombinant defective adenoviruses (serotype 5) encoding individual epitope tagged compo-
nents of the pentameric complex were generated as high titer stocks by Welgen Inc. on
HEK293 cells. The C-terminal epitopes tagged ORFs from plasmids pAcGFPNgH, pmCher-
ryNgL, pGP129myc, pGP131HA, pGP133FLAG were each placed under HCMVMIE
enhancer promoter control in the E1 locus of the defective Ad vectors using a E1 shuttle vector
(Welgen Inc.) to generate recombinant defective adenoviruses designated AdgHGFP,
AdgLmCherry, AdGP129myc, AdGP131HA, AdGP133FLAG respectively. A defective Ad vec-
tor encoding GFP (AdGFP) was also used in control expression studies [36].
RT-PCR
Time point samples were taken from wild type GPCMV infected GPL cells in a six well dish
(moi = 1 pfu/cell) at 48 hr post infection. RT-PCR was performed essentially as described in
Coleman et al. [36]. Based on the original analysis of the full length GP128-133 locus [28, 87],
there are five genes designated GP128, GP129, GP130, GP131 and GP133. Based on co-linearity
to HCMV as well as encoded proteins, two of these genes are direct homologs of HCMV
UL128 (GP129) and UL130 (GP131) [28]. GP133 has a weak homology to UL131[90]. Gene
expression in the GP128-133 locus at late stage infection of SG GPCMV was investigated via
RT-PCR assay as previously described [36] using the following primer pairs: RTGP128F/
RTGP128R; RTGP129F/RTGP129R; RTGP130F/RTGP130R; RTGP131F/RTGP131R;
RTGP133F/RTGP133R and control GAPDH (GAPDHRTF/GAPDHRTR) as described in S1
Table. Results demonstrated that the previously identified genes were all expressed in SG
GPCMV infected cells (S2 Fig).
Immunoprecipitation assays
Immunoprecipitation (IP) assays were carried out on plasmid transfected or recombinant Ad
transduced fibroblast cells using commercial GFP-trap reagent (ChromoTek) or RFP-trap
(ChromoTek) following manufacturer’s protocols and inclusion of protease inhibitor cocktail
(Pierce) in cell lysates. Samples were subsequently analyzed by SDS-PAGE (4–20% gradient
gel) and western blot using specific anti-epitope tag antibodies: HA (Novus Biologicals); FLAG
(Novus Biological); GFP (Santa Cruz Biotechnology); Myc-c (Novus Biologicals); and mCherry
(Clontech Laboratories). Appropriate secondary anti-mouse or anti-rabbit HRP conjugate
(Cell Signaling Technology) were also used following standard western blot protocol as previ-
ously described [36].
Specific GPCMV protein antibodies
Custom antibodies to GPCMV gH, IE2 and GP131 were generated by Genescript to specific
peptide sequences (rabbit polyclonal) or to purified recombinant (E.coli) protein (mouse
monoclonal). Rabbit polyclonal antibody sera were separately generated against gH and IE2
using the peptide immunogen of RTDLSSPTEELTSP (for gH) or CRKTRPAKRPRSNDE (for
IE2). Mouse monoclonal antibody to GP131 was generated against recombinant purified pro-
tein and hybridoma antibody screened for activity to GP131. Rabbit or mouse IgG was column
purified and resuspended at a concentration of 100 μg/ml. Antibody specificity was verified by
both western blot and immunofluorescence assay of transiently expressed proteins (gH, IE2 or
GP131) in fibroblast/epithelial cells using appropriate plasmid expression vectors for gH, IE2
or GP131 following standard protocols [36].
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Bafilomycin inhibition of virus entry by pH-dependent endocytosis
Epithelial cells or GPL fibroblast cells on coverslips six well dishes were pretreated with complete
media containing either 0 or 50nM bafilomycin A1 (Sigma) for 1 hr at 37˚C followed by virus infec-
tion using FRTGP129 virus (MOI = 1pfu/cell) for 1hr at 37 ˚C. All further incubations were per-
formed at the same concentration as pretreatment in complete media. Cells were fixed at 24 hr post
infection in 100%methanol at -20˚C and immunostained for IE2 protein and cytokeratin as
described in materials andmethods. Counts were made of IE2 positive cells in random fields. Statisti-
cal analysis was performed using student T-test on the percent of cells infected in thirty random fields
of view, each contained ~100 cell nuclei, for each condition. The number of treated cells infected was
represented as a percentage of the number of infected untreated cells. Results shown in S15 Fig.
Statistical analysis
In pathogenicity studies, viral load in similar organ tissue from GPCMV infected animals at
specific days post infection were compared by Student t-test (GP129FRT vs SG GPCMV and
GP129FRT vs NRD13). In congenital studies, pup outcome and transmission rates were com-
pared by Fisher’s exact test. GPCMV viral load in specific target organs of pups were compared
by Student t-test. All comparisons were two-tailed. Student t-test analysis was also carried out
for virus infection of cells in bafilomycin virus cell entry studies (S15 Fig).
Supporting Information
S1 Table. Oligonucleotides used in PCR and RT-PCR reactions.
(DOCX)
S2 Table. Predicted molecular weights of pentameric complex proteins.
(DOCX)
S1 Fig. Annotated genome sequence for the GP128-GP133 locus in SG and ATCC lab
adapted deletion virus. GPCMV GP128-134 sequences based on GenBank Accession #
AB592928.1. GPCMV nucleotide base co-ordinates indicated in brackets. GP128 (195,713–
196,768) highlighted in blue; GP129 (196,745–197,439 complement) highlighted in green;
GP131 (197,444–198,102 complement) highlighted in orange; GP133 (198,102–198,485 com-
plement) highlighted in yellow GP134 (198,579–199,262 complement) highlighted in grey.
Primers P1/P2 (S1 Table) used for verification of intact or deleted GP129-133 region are
bolded in black. Deleted region (1.6 kb) of lab-adapted virus is underlined (196,925–198,573).
Sequence deletion for GP129-GP131 mutant (197,292–198,090) start and end sequence of dele-
tion designated by square (□). Sequence deletion for GP133 mutant (198,361–198,489) start
and end sequence designated by circle (). For the GP128mutant, an EcoR V site (196,234–
196,239) within GP128 was the site of a Km cassette insertion (GATATC) which disrupted the
ORF.
(TIF)
S2 Fig. RT-PCR assay of genes transcribed in the GP128-133 locus of SG GPCMV. Individ-
ual RT-PCR primer sets (see material and methods and S1 Table) were designed for GP128,
GP129, GP130, GP131and GP133 based on defined sequences. RT-PCR was performed as pre-
viously described [36]. RT-PCR products were analysed by agarose gel electrophoresis. Lanes:
1–3, GP128; 4–6 GP129; 8–10 GP130; 11–13, GP131. Lanes 1, 4, 8, 11 and 16 SG GPCMV
infected cells. Lanes 2, 5, 9, 12 and 17 mock infected cells (control). Lanes 3, 5, 9, 12 and 18 no
RNA control. Lanes 7,14 and 15,100 bp ladder (NEB).
(TIF)
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S3 Fig. Characterization of guinea pig epithelial cells. (i).GPL fibroblast vs Epithelial cell western
blot for cytokeratin 18. Cell lysates from ~1x106 GPL and EPI cells were analyzed by western blot
using a 4–20% SDS-PAGE gel and probed with anti-Keratin 18 (DC10) Mouse mAb (Cell Signal-
ing) and secondary anti-mouse IgG-HRP conjugate. (ii). Immunofluorescence for cytokeratin
expression in EPI cells. Monolayers of EPI (images A, B & C) and GPL (images D, E & F) cells
were immunostained using Pan-Keratin (C11) mouse mAb (Images A and D) as described in
materials and methods. Cell were also stained with high-affinity F-actin probe, anti-phalloidin-
Alexa Fluor 568 (ThermoFisher scientific) (Images B and E). Cells were counterstained with DAPI
(merged images C and F). Images were taken at 40X using a Olympus IX81 confocal microscope.
(TIF)
S4 Fig. PP ATCC mutant virus is impaired for growth on epithelial cells. EPI and GPL cells
were infected at a moi of 1 pfu/cell. At 48 hr post infection cells were fixed and stained for viral
(IE2) and epithelial cell markers as described in materials and methods. Immunofluorescence
images of EPI cells: A, IE2; B, pan-keratin; C, merged A and B with DAPI stain. Immunofluo-
rescence images of GPL cells: D, IE2; E, pan-keratin; F, merged E and F with DAPI stain.
Images at x60 maginification.
(TIF)
S5 Fig. Recombinant adenoviruses encoding PC components and co-expression on EPI
cells. (i) Components of the pentameric complex (gH, gL. GP129, GP131 and GP133) were
individually cloned as C-terminal epitope tagged ORFs into recombinant defective adenovirus
shuttle vectors and recombinant viruses generated for each component. Genes were expressed
under HCMVMIE enhancer expression as illustrated. Predicted encoded protein is indicated
for each construct. (ii) Cellular co-localization of pentameric complex components in guinea
pig epithelial cells in the absence of other GPCMV proteins. EPI cells were transduced with
defective recombinant Ad constructs of the pentameric complex as described in materials and
methods. gH expression detected under fluorescence (gHGFP). gHGFP localization (panels A,
E, and I), gL expression detected under fluorescence (gLmCherry). gLmCherry localization
(panels B, F, & J). GP129myc localization using immunofluorescence anti–myc antibody/ Cy5
(Panel C). GP131HA localization using anti-HA antibody/Cy5 (G). GP133FLAG localization
using anti-FLAG antibody/Cy5 (K). Panel D (merged A, B & C) for gH, gL and GP129, Panel
H (merged E, F & G) for gH, gL and GP131. Panel L (merged I, J & K) for gH, gL and GP133.
Merged images also counterstained with DAPI.
(TIF)
S6 Fig. Tunicamycin treatment and expression of GP129, GP131 and GP133 proteins.
Transient expression of GP129, GP131 and GP133 was evaluated in the presence or absence of
tunicamycin treatment. Separate 6 well plates of epithelial cells were transduced with recombi-
nant Ad vectors encoding GP129, GP131 or GP133. Expression occurred in the presence or
absence of tunicamycin as previously described (36). After overnight expression, monolayers
were either harvested for western blot analysis (A-C) or fixed for immunofluorescence assay
(D-I). Western blot assays (A-C). Lanes: 1, 4 and 7 mock infected cells; 2 and 3 AdGP129myc
transduced cells; 5 and 6 AdGP131HA; 8 and 9 AdGP133FLAG. Lanes 3, 6 and 9 represent
cells treated with tunicamycin. Immunofluorescence assays: D and G, AdGP129myc; E and H,
AdGP131; F and I, AdGP133FLAG. Tunicamycin treated monolayers (G, H and I). For west-
erns and immunofluorescence assays detection of epitope tagged protein was carried out as
described in materials and methods using appropriate mouse primary antibody (anti-myc,
anti-HA or anti-FLAG).
(TIF)
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S7 Fig. RFP-trap immunoprecipitation of GPCMV PC. GPCMV PC IP via RFP trap directed
to gLmCherry. (i)- (ii)Western blot analysis of immunoprecipitated GPCMV PC. Immuno-
precipitation via RFP trap directed to gLmCherry in cells transduced with defective recombi-
nant Ad vectors for all PC components as described in materials and methods.
Immunoprecipitated proteins detected by western blot using epitope specific antibodies. Lanes:
1–4, anti-GFP for gH; 5–7, anti mCherry for gL; 8–11, anti-MYC for GP129 12–14, anti-HA
for GP131; 15–17, anti-FLAG for GP133. Lanes 2, 5, 9 12 and 16 are total cell lysate. Lanes 4, 7,
11 14 and 17 are immunoprecipitation elusion. Lanes 3, 6, 10 13 and 16 are post bind wash.
Lanes 1 and 8 are mock infected total cell lysate samples. (iii)-(iv) Control IP of the pentameric
complex in the absence of gLmCherry with substituted mCherry control in the presence of gH,
GP129, GP131, GP133. Control IP western blot lanes: 1–4, anti-GFP; 5–7, anti-mCherry (for
mCherry); 8–11, anti-MYC; 12–14, anti-HA; 15–17, anti-FLAG. Total cell lysate (lanes 2, 5, 9,
12 and 15). Post bind wash flow through (lanes 3, 6, 10, 13, 16). Immunoprecipitation elusion
(lanes 4, 7, 11, 14 and 17). Mock infected total cell lysate (lanes 1 and 8).
(TIF)
S8 Fig. BLAST alignment of GP129 with GP129C-terminal mutants. A BLAST alignment
(MacVector) of the C-terminal regions of the mutant GP129 (NRD13 and GP129UL128) in
alignment with wild type GP129 predicted amino acid sequence. NRD13 is a naturally selected
GP129 mutation found in the second generation GPCMV BAC GP129UL128 is a C-terminal
deletion mutant which encodes 48 codons from the C-terminal of UL128 HCMV (Merlin).
(TIF)
S9 Fig. Triplex formation immunoprecipitation assays (full length blots). GP129, GP131,
GP133 and gO were evaluated for an ability to form triplex complexes with gH and gL. Tran-
sient expression of epithelial cells with gHGFP, gLmCherry, GP129myc, GP131HA and
GP133FLAG was as described in materials and methods. Evaluation of triplex formation was
by cellular colocalization or by GFP trap immunoprecipitation assay (see Fig 3). This
Figure shows the full length western blots of the results from Fig 3. Western blots of triplex
immunoprecipitations: (E) gHGFP/gLmCherry/GP129myc; (J) gHGFP/gLmCherry/GP131HA
triplex; (O) gHGFP/gLmCherry/GP133FLAG triplex; (T) gHGFP/gLmCherry/gOFLAG tri-
plex. Lanes: 1, 4 and 7 total cell lysate; 2, 5 and 8 wash flow through; 3, 6 and 9 immunoprecipi-
tation. Specific proteins detected indicated in brackets under each blot. Detection by
appropriate primary antibody: gHGFP (anti-GFP); gLmCherry (anti-mCherry); GP129myc
(anti-myc); GP131 (anti-HA); GP133 (anti-FLAG).
(TIF)
S10 Fig. GP25/GP26 locus sequence of GPCMV and unique BamHI site. GPCMV GP25-26
sequences based on GenBank Accession # AB592928.1. GP25 flanking sequence (yellow);
GP26 flanking sequence (green). Unique BamH I site (bold/blue) for SV40 promoter/ SV40
polyA insertion site. Stop codons for GP25 and GP26 are in red text.
(TIF)
S11 Fig. Generation of a GP25/GP26 locus shuttle vector and insertion of a GP129myc
cDNA under SV40 promoter control in an ectopic location in GPCMV. (i) Location of the
GP26/GP26 locus in the GPCMV Hind III genome map. Enlarged area shows the GP25/GP26
region amplified by PCR (genome co-ordinates 37,672–38953) using GP25/GP26 primers (S1
Table) and cloned into pUC19 as a EcoRI/ HindIII fragment of 1.3 kb in size to generate
pUCGP25/26. The BamHI site in the intergenic site was further modified. (ii) A SV40 pro-
moter/ poly A cassette was inserted to generate pSIGP25/26 (1). Next the GP129myc cDNA
was cloned under SV40 control to generate pGP129Link1 (2). A Km cassette was then
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introduced downstream of the SV40 polyA sequence to generate pGP129LinkKmFRT (3). This
shuttle vector was used for recombination with the GPCMV BAC as described in materials and
methods. Modified GP25/GP26 locus in the GPCMV BAC genome could be identified by PCR
(3.7 kb PCR). The GPCMV BAC locus could be further modified to remove the Km cassette by
FLP recombinase (4). (iii) PCR analysis of various GPCMV BAC mutants described in S12 Fig
with modified GP25/GP26 locus. PCR analysis with GP25/GP26 primers (S1 Table). PCR prod-
ucts analyzed by agarose gel electrophoresis. Lanes: 1) kb ladder (NEB); 2) NRD13 (wt GP25/
GP26 locus); 3) Modified NRD13 locus encoding GP129 and Km (see diagram 3 section (ii)
S11 Fig); 4) Modified NRD13 locus encoding GP129 with Km excised (see diagram 4 section
(ii). BAC and virus generated GP129FRT; 5) GP128 mutant; 6) GP131 mutant; 7) GP133
mutant; 8) GP129FRT/GP74Km; 9) GP129FRT/GP55Km.
(TIF)
S12 Fig. Restriction Profile Analysis GPCMV BACmutants.Wild type GPCMV BAC was
mutated to generate a series of GP128-GP133mutants. At least two independent mutants were
analyzed per gene knockout but only one mutant is shown in the Figure. Both EcoR I (Ec) and
Hind III (Hd) restriction profile analysis were performed for each mutant but only one profile
is shown for each mutant to reduce repetition. Specific band shifts are indicated as original
wild type band (yellow) and modified mutant band (red). (i)-(iii) Restriction profiles of indi-
vidual mutants. Lanes: 1, mutant; 2, wild type GPCMV BAC. Profiles: (i) GP128Km; (ii)
GP129-131Km; (iii) GP133Km. (iv)-(v) Restriction profile of double mutant GP128FRT/
GP129LinkKm (iv) and GP129-131FRT/GP129LinkKm (v). Double mutants contain an addi-
tional modification with an ectopic insertion of a GP129myc cDNA into the GP25/GP26 inter-
genic locus. Profiles compared to wild type GPCMV BAC or GP129FRTKm GPCMV BAC
(GP129 insertion into the GP25/GP26 locus). BAC profiles. Lanes: 1, double mutant; 2,
GP129FRTKm; 3, wild type GPCMV. Modified GP25/GP26 locus indicated. (vi) Generation of
GP74 knockout mutant on a GP129 positive background. Restriction profile of NBGP129FRT/
GP74Km (lane 1) vs wild type GPCMV BAC (lane 2). Modified GP74 locus indicated. (vii)
Generation of GP55 mutant on a GP129 positive background. GPCMV BAC EcoRI profile
analysis: Lanes: 1, GP129FRT/GP55km; 2, GP129FRT; 3, NRD13 (original BAC). Wild type
band indicated (yellow dot) and modified band indicated (red dot).
(TIF)
S13 Fig. Growth curves of GP128-GP133 locus mutants on GPL cells and tropism of GP131
and GP133 mutants for epithelial cells. (i) Growth curve of various GPCMV GP128-GP133
mutants on GPL cells. Moi per mutant virus was 1pfu/cell. Samples taken at 1–10 days post
infection and titrated in duplicate on GPL cells as described in materials and methods.
GPCMV GP128-133 locus mutants: GP128mutant (GP128FRT/GP129Link); GP133mutant
(GP133FRT/GP129Link); GP131mutant (GP131FRT/GP129Link); GP129mutant (NRD13).
(ii) Comparative growth of GP131 and GP133mutants on GPL and EPI cells. GPL (panels A
and C) and EPI (panels B and D) cells were infected at a moi of 1pfu/cell with respective
mutant viruses: GP133 mutant, panels A & B; GP131 mutant, panels C & D. Virus growth on
cells evaluated at approximately 3 days post infection for GFP reporter gene expression and
cells counter stained for cell nuclei with DAPI. Growth curve study carried out with Cre treated
BAC excised virus stocks and virus GFP fluorescence studies (ii) carried out with GFP+ non
cre excised virus stocks.
(TIF)
S14 Fig. Both PC and gB are required for GPCMV infection of epithelial cells. PC+/gO+/
gB negative GPCMV BAC mutant (GP129FRT/GP55Km) transfected onto epithelial cells
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failed to produce infectious virus (A). Single transfected cells identified by GFP reporter gene
expression; gB rescue (GP129FRT/GP55Km rescue). Mutant gB BAC (GP129FRT/GP55km)
was co-transfected onto GPL cells with a GP55 rescue fragment to restore epithelial tropism.
Virus spread detected by GFP reporter gene expression at day 12 post transfection restored
(B).
(TIF)
S15 Fig. Inhibition of GPCMV epithelial infection via Bafilomycin A1 treatment. EPI or
GPL cells were untreated or pretreated with 50nM bafilomycin A1 for 1 hr prior to
GPCMVGP129FRT virus infection (MOI = 1pfu/cell). (i) Virus infection of EPI cells in pres-
ence or absence of bafilomycin. Images of random cell fields immunostained for cytokeratin
and GPCMV IE2 protein. Images of cells: mock infected EPI cells treated with 50nM bafilomy-
cin A1 (images A-C); untreated EPI cells infected with FRT virus (images D-F); pretreated with
50nM bafilomycin A1(images G-I). Cells immunostained as described in materials and meth-
ods: anti-pan-keratin antibody with secondary anti-mouse IgG-TritC (A, D, and G) and anti-
IE2 antibody with secondary anti-rabbit IgG-FitC (B, E, and H). Cells were counter stained
with DAPI (C, F and I). Images were taken at 40X magnification using spinning disc confocal
microscope (Olympus). (ii) Percentage of GPCMV infected cells (GPL or EPI) either bafilomy-
cin treated or untreated. Virus detected by IE2 antigen expression via immunofluorescence
assay using anti-IE2 antibody as described in materials and methods. Thirty random fields for
each 3 independent experiments per treatment were counted. Statistical analysis was per-
formed with student t-test.
(TIF)
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